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Summary
Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has
been implicated in the development of chronic metabolic diseases like obesity, type
2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). In this review,
available evidence is discussed on postprandial glucose in relation to body weight
control, the development of oxidative stress, T2DM, and CVD and in maintaining
optimal exercise and cognitive performance. There is mechanistic evidence linking
postprandial glycaemia or glycaemic variability to the development of these
conditions or in the impairment in cognitive and exercise performance. Neverthe-
less, postprandial glycaemia is interrelated with many other (risk) factors as well
as to fasting glucose. In many studies, meal-related glycaemic response is not
sufficiently characterized, or the methodology with respect to the description of
food or meal composition, or the duration of the measurement of postprandial
glycaemia is limited. It is evident that more randomized controlled dietary inter-
vention trials using effective low vs. high glucose response diets are necessary in
order to draw more definite conclusions on the role of postprandial glycaemia in
relation to health and disease. Also of importance is the evaluation of the potential
role of the time course of postprandial glycaemia.
Keywords: Health, physiological effects, postprandial glycaemia, risk factors.
Abbreviations: ACC, acetyl-CoA carboxylase; ATP, adenosine triphosphate;
AUC, area under the curve; BBB, blood–brain barrier; BMI, body mass index;
CCK, cholecystokinin; CHD, coronary heart disease; CRP, C-reactive protein;
CVD, cardiovascular disease; EI, energy intake; FFA, free fatty acid; GI, glycaemic
index; GIP, glucose-dependant insulinotropic polypeptide; GL, glycaemic load;
GLP-1, glucagon-like peptide-1; HDL, high-density lipoprotein; HGI, high gly-
caemic index; HOMA, homeostatic model assessment; IGT, impaired glucose
tolerance; IL, interleukin; IMT, intima-media thickness; IPD, individual partici-
pant data; LDL, low-density lipoprotein; LGI, low glycaemic index; MAGE, mean
amplitude of glycaemic excursions; NO, nitric oxide; OGTT, oral glucose toler-
ance test; PKC, protein kinase C; PYY, peptide YY; RAGE, advanced glycated
end-product receptor; RCT, randomized controlled trial; RR, relative risk; SCFA,
short-chain fatty acid; SD, standard deviation; SL, study level; TG, trigylceride;
TNFalpha, tumour necrosis factor alpha.
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Introduction and background
Carbohydrates are, on a weight basis at least, the most
important nutrient of the human diet, after water. In terms
of fulfilling energy requirements, they should also be the
major component of the diet according to nutritional
guidelines: carbohydrates should represent 45–55% of
our daily energy intake (EI), 10–15% being simple carbo-
hydrates or sugars, the remainder being starches and oli-
gosaccharides. Carbohydrates present a daily metabolic
challenge for the body, as glucose is the prime fuel normally
used by brain cells and many organs. Although the brain
and organs rely on glucose for their energetic needs, the
body can only store, mainly in the liver and muscles, up to
about 1 kg of glucose, which represents no more than 2 d
of consumption. To manage this metabolic challenge, there
is complex machinery balancing the influx of carbohy-
drates from the diet digested in the gut to the cells, partly
for storage and partly for immediate oxidation. Blood gly-
caemia reflects this balance, and there are two hormonal
systems to limit, on the one hand, the increase of blood
glycaemia and, on the other, the decrease to ensure a proper
permanent delivery of glucose to cells.
Postprandial glycaemia (and related insulinaemia and
lipidaemia) has been implicated in the aetiology of chronic
metabolic diseases such as type 2 diabetes mellitus (T2DM)
and cardiovascular disease (CVD). Obesity is the most
important risk factor for the development of these
metabolic diseases. The worldwide prevalence of over-
weight (body mass index [BMI]  25 kg m-2) and obesity
(BMI  30 kg m-2) has risen dramatically in recent decades
and is still on the increase. Raised BMI is a major risk
factor for chronic diseases such as CVD (mainly heart
disease and stroke), type 2 diabetes (also rapidly becoming
a global epidemic), musculoskeletal disorders (especially
osteoarthritis) and some cancers (e.g. endometrial, breast
and colon) (1,2). Obesity and related health complications
lead to reduced quality of life, massive healthcare costs and
ultimately premature death, indicating the urgency for the
identification of simple cost-effective strategies for preven-
tion and management.
Pharmacological manipulation of postprandial glucose
by acarbose, an alpha-glucosidase inhibitor, may decrease
progression to diabetes by 25% (3). However, manipula-
tion of postprandial glucose by nateglinide – which stimu-
lates insulin release – was unable to reduce diabetes
incidence (NAVIGATOR trial [4]), suggesting that the
mechanisms of action for reducing postprandial glucose
may be a determinant of the final effect. Furthermore,
recent large-scale lifestyle intervention studies indicate that
lifestyle intervention in impaired glucose-tolerant subjects
improves glucose tolerance and reduces diabetes risk by
30–60% (5–7). The underlying mechanisms relating
reduced postprandial glucose to the prevention of disease
are less clear. The level of postprandial glycaemia has been
implicated in body weight control either via an effect on
appetite or via an effect on nutrient partitioning of mark-
edly increased insulin and glucose concentrations (8). The
latter may promote fat storage in adipose and non-adipose
tissues through effects on adipose tissue lipolysis and
skeletal muscle fat oxidation. Greater postprandial fat
storage in the liver and skeletal muscles has been associated
with the development of insulin resistance (IR) (9). There
are increasing indications that both upward and downward
fluctuations of post-meal glucose concentrations may
be particularly important in the aetiology of chronic
disease. It has been hypothesized that a chronic high early
glycaemic response followed by late depression of blood
glucose below baseline levels (reactive hypoglycaemia) and
increased free fatty acid (FFA) concentrations is associated
with the development of IR (10). Addtionally, fasting and
postprandial glucose concentrations represent a strong risk
factor for the development of T2DM and CVD by promot-
ing oxidative stress, inflammation and endothelial dysfunc-
tion (as reviewed in the sections on oxidative stress and
inflammation, on the prevention of diabetes and IR and on
cardiovascular prevention in this article).
The scope of the present overview is, firstly, to discuss the
available evidence on the role of postprandial glucose in
relation to body weight control, the development of oxida-
tive stress, diabetes and CVD. Figure 1 gives an overview of
the putative relationships between postprandial glycaemia
and chronic disease, which will be addressed in the differ-
ent sections of this review. Subsequently, physical exercise
is addressed as an important strategy to manage postpran-
dial blood glucose within ‘more healthy levels’. Finally,
chronic diseases such as obesity and diabetes are increas-
ingly being associated with cognitive decline. Glucose
forms the major energy substrate of the brain and is central
to the normal functioning of the central nervous system.
The available knowledge on postprandial glucose response
in relation to cognitive functions is, therefore, addressed in
the final section of this article, which ends with a brief
overall discussion.
As carbohydrate is the main dietary component affecting
glycaemia, many studies that are described involve the
effects of dietary carbohydrate. Both the amount and type
of carbohydrate have an effect on both postprandial gly-
caemia and insulinaemia, with differences not explained by
glucose chain length. In 1981, the concept of glycaemic
index (GI) was introduced by Jenkins et al. (11) to quantify
the glycaemic response to carbohydrates in different foods.
Glycaemic load, the mathematical product of the GI of a
food and its carbohydrate content, has been proposed
as a global indicator of the glucose response and insulin
demand induced by a serving of food. In practice, these
reflect a total glycaemic response to a food or diet regard-
less of the food components responsible or the shape of the
924 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
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glycaemic response. In addition to these factors, the shape
of the glycaemic curve is studied using different measures
involving the total glucose response, the incremental
response, the maximum amplitude of glucose excursions,
the mean amplitude of glycaemic excursions (MAGE)
index or the standard deviation (SD) around the mean
glucose value. The number of different measures of glycae-
mic variability illustrates that it is a complex phenomenon
including both intraday and interday variability. Finally,
the question as to whether the relationship between
glycaemia, health and disease involves a continuous rela-
tionship, or if there are clear thresholds for effects, will be
specifically addressed because this issue is important for
disease prevention.
Postprandial glycaemia and weight
management1
Introduction
The aim of this section is to collate and evaluate the evi-
dence for the impact of postprandial glycaemia on weight
management in healthy (non-diabetic) subjects. The evi-
dence for the effects of postprandial glycaemia on obesity
prevention comes from both short (1 d) and longer-term
studies (8 d) investigating the effects of dietary interven-
tions on appetite control and body weight. Additionally,
there are indications that postprandial glycaemia may
affect body weight control by affecting the balance between
fat and carbohydrate oxidation, thereby affecting energy
expenditure, but this mechanism is probably of lesser
importance than appetite control in the regulation of body
weight. The capacity of any food to suppress hunger and
inhibit eating is mediated by processes that can be roughly
classified as sensory, cognitive, post-ingestive (but pre-
absorptive) and post-absorptive. Together these processes
have been referred to as the satiety cascade (12,13). The
satiety cascade embodies the important distinction between
satiation and satiety, the two main mechanisms upon which
appetite control is based. Satiation can be defined as the
process or set of processes that bring a period of eating to
a close (or intra-meal satiety). Satiety, however, is typically
defined as the state of inhibition over further food intake
once a period of eating has ended (or inter-meal satiety).
Satiety is therefore a short-term parameter that is generally
not assessed over the long-term. Although enhanced satiety
might improve tolerance to or compliance wth consump-
tion of energy-reduced foods, a change in hunger or fullness
(for example) will only be of clinical significance for weight
control if it can be translated into a decrease in actual EI
that results in either weight loss or maintenance over time.
Short-term studies have the disadvantage of not predicting
food intake or benefits related to increased dietary toler-
ance or compliance during the next days or weeks if the diet
is continued. It is, therefore, necessary to examine the long-
term effects of dietary manipulations on body weight to
determine if short-term effects of certain foods/food com-
ponents on satiety translate into weight loss. Blundell and
colleagues (14) have now provided guidance on good prac-
tice when carrying out research to assess the impact of
foods and food ingredients on the expression of appetite.
This is especially important in the light of the regulatory
procedures to be implemented regarding satiety and appe-
tite claims on foods.
Postprandial glycaemia and appetite control:
evidence from short-term (acute) dietary
intervention studies
Short-term effects of GI interventions on postprandial
glycaemia and satiety
It has been suggested that low GI (LGI) foods increase
satiety compared with high GI (HGI) foods (15,16). Many
short-term studies (lasting for a single meal or a single day)
have addressed the question of whether consumption of
LGI foods reduces hunger and/or promotes satiety relative
1The main authors of this section are Clare Lawton and Jens Juul Holst
plus Signe Sørensen Torekov for the incretin parts.
Figure 1 Putative relationships between postprandial glycaemia and
risk factors for obesity, diabetes and cardiovascular disease.
FFA, free fatty acid.
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to consumption of HGI foods. Table 1 summarizes the
results of these acute studies on appetite control in healthy
participants.
Raben (17) conducted a systematic review of published
human intervention studies comparing the effects of HGI
and LGI foods or diets on appetite, food intake, energy
expenditure and body weight (see Table 1 for details of
the short-term studies reviewed). Within this she reviewed
the results of 31 short-term studies (<1 d) and 20 longer-
term studies (<6 months; see section on long-term effects
of GI interventions on postprandial glycaemia and body
weight control). The short-term studies comprised a total
of 35 different meal tests (because 4 studies reported the
results of 2 separate meal tests). Overall, Raben concluded
that the data from the short-term human intervention
studies included in her review did not provide convincing
evidence that LGI meals have a more positive effect on
satiety, hunger and food intake than HGI meals. Around
this time a couple of other reviews (15,18) were more
positive in their conclusions regarding LGI foods and
appetite, but these included fewer studies (16 and 20 meal
tests, respectively).
Bornet et al. (19) conducted a systematic review that
examined 32 human studies that had investigated the rela-
tionship between the glycaemic response to foods and its
impact on satiety and weight management (Table 1). Both
the 25 short-term studies (1 d or less) with liquid carbohy-
drates (e.g. glucose or fructose in water) or foods and
longer-term studies (2 weeks–6 months; see section on
long-term effects of GI interventions on postrandial glycae-
mia and body weight control) were included.
Bornet and colleagues (19) concluded that whatever the
method used to assess satiety (subjective or objective) and
despite the possible contribution of some confounding
factors (e.g. fibre and palatability), more than half of the
reviewed studies supported an increased short-term satiety
with LGI foods or meals compared with HGI foods or
meals. In addition, this result was not contradicted by those
studies that were inconclusive.
Limited research in humans suggests that slowly digested
starch may blunt the postprandial increase and subsequent
decline of blood insulin and glucose concentrations, leading
to prolonged satiety, compared with more rapidly digested
starch. A study by Sands and colleagues (20) examined the
postprandial metabolic and appetite responses to 50 g of
available carbohydrate given as waxy maize starch (WM, a
slowly digested starch), a maltodextrin-sucrose mixture
(MS, rapidly digested carbohydrate) or white bread
(control). Subjects were 12 (6 men, 6 women) young,
healthy, normal-weight, insulin-sensitive adults. Postpran-
dial plasma glucose and insulin, energy expenditure, and
subjective appetite (hunger, fullness and desire to eat using
13-point linear scales) were measured over 4 h. The
authors found that consumption of the slowly digested
WM starch, compared with MS, produced blunted 4-h
plasma glucose and insulin responses (P < 0.001).
However, postprandial energy expenditure and appetite
responses did not differ between the WM and MS treat-
ments. These results are similar to those of Wachters-
Hagedoorn et al. (21), who reported that 50 g of available
carbohydrate from uncooked corn starch (a slowly digested
starch) led to smaller glucose and insulin area under the
curve (AUC) compared with 50 g of glucose. Slowly
digested starches may therefore be a suitable choice of
carbohydrate when a slower, more prolonged period of
glucose absorption is desired, and may eliminate the poten-
tial for depression of blood glucose below baseline levels
(reactive hypoglycaemia) after the ingestion of a quickly
digested food. Although the study by Sands and colleagues
(20) did not find differences in hunger or satiety among
the study treatments, the authors acknowledge that their
results should be viewed with caution until confirmed
(because of the possible confounding effect of food form/
palatability). Granfeldt et al. (22), for example, studied the
satiety responses to slowly digested barley products com-
pared with a white bread control. The barley products were
found to elicit greater satiety than white bread, and this
was found to be inversely correlated with lower glucose
responses. Additionally, recent results with cereal-based
breakfasts have shown that the magnitude of reactive
hypoglycaemia (i.e. depression of blood glucose below
baseline levels) was negatively correlated to subjective
rating of satiety in the late postprandial phase. Also, a low
incremental insulin peak after breakfast was associated
with less severe reactive hypoglycaemia and with a milder
recovery of plasma ghrelin (which rises with hunger) (23).
In a follow-up study highlighting rye breakfast meals, a
higher glycaemic profile (glycaemic peak, defined as the
quota between glycaemic peak concentration and time
duration of glycaemia above fasting level, and measured as
min mmol-1 L-1), was related to a lowered desire to eat
before lunch (AUC 210–270) and to a lower concentration
of ghrelin in the late postprandial phase (270 min), which
in turn related to a lower voluntary EI at a subsequent
buffet lunch meal (24).
The influence of postprandial glycaemic responses per
se on satiety in the short-term
Although it has been suggested that foods with an LGI
increase satiety (25,26), the evidence that glycaemic
responses per se influence satiety is not clear. Wolever et al.
(27) state that neither the timing nor the direction of the
effect of LGI foods on satiety or food intake is consistent
and that results are often confounded by lack of control
of variables other than glycaemic response, which could
account for increased satiety, such as dietary fibre (26),
protein (28) and meal volume (29). The glucose-lowering
effects of dietary fibre, protein and fat are discussed in the
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section ‘Effects of other dietary factors on postprandial
glycaemia in both the short- and the long-term’.
Wolever and colleagues (30,31) found that the glycae-
mic responses elicited by exactly the same test meal vary
from day to day within subjects with a mean coefficient
of variation of ~25% in normal subjects. In view of this,
Wolever and colleagues (27) postulated that if glycaemic
responses affect satiety then variations in response after
the same test meal should be associated with changes in
satiety. They designed and carried out a study to test this
hypothesis but found that the day-to-day variation in gly-
caemic response elicited by white bread was not related to
variation in satiety in non-obese subjects. The researchers
concluded that the effect of LGI foods on short-term
satiety and food intake is due to factors other than blood
glucose response (e.g. fibre and protein content). This
conclusion is also shared by Peters and co-workers (32),
who examined the postprandial glucose, insulin and
appetite responses to drinks differing only in rate and
digestibility of carbohydrate. This was achieved by com-
paring different glucose polymers: maltodextrin (MDX,
rapidly digestible), medium-chain pullulan (MCP, slowly
but completely digestible) and long-chain pullulan (MLP,
indigestible). It was hypothesized that the MCP would
result in a more sustained postprandial blood glucose and
plasma insulin response, leading to a reduction in appetite
as compared with MDX. However, although the digest-
ibility, glucose and insulin data confirmed the rapid, slow
and indigestible nature of MDX, MCP and MLP, respec-
tively, only MLP reduced appetite compared with the
MDX control, whereas the MCP did not. Hence, glycae-
mic responses per se were found to have minimal effects
on appetite when tested in products differing only in the
rate and digestibility of carbohydrate.
In an attempt to clarify the roles of blood glucose and
insulin in short-term appetite regulation, Flint and col-
leagues (33) conducted a meta-analysis of all test meal
studies having individual participant data (IPD) on
blood glucose, insulin and subjective appetite sensations
(using visual analogue scale) conducted in their department
(between 1990 and 2003). Seven single test meal studies
with a total of 136 (131 males, 5 females) healthy normal-
weight (N = 92) or overweight participants (N = 44, all
male) were included. All test meals were served as breakfast
after an overnight fast. In six of the seven studies, the
participants were served an ad libitum lunch meal at the
end of the postprandial period (180–315 min). In each
study, insulin, blood glucose and subjective appetite
(hunger/satiety) were measured frequently during the post-
prandial period.
Data were analysed by fixed-effects study level (SL)
meta-regression analysis and IPD regression analysis on all
subjects and as subgroup analyses on normal-weight and
overweight participants separately. In the SL analysis a
greater postprandial insulin response was associated with
decreased hunger in all subjects and in the normal-weight
and overweight subgroups (P < 0.019). Furthermore, a
greater postprandial insulin response was associated with
increased satiety in normal-weight subjects (P = 0.004) and
with lower EI from the ad libitum lunch (EI) in overweight
subjects (P = 0.022). Multivariate IPD analysis showed
similar associations but only in the normal-weight sub-
group for hunger, satiety and EI (P < 0.028) and in all
subjects for EI (P = 0.016). The only association involving
blood glucose was the multivariate IPD analysis showing a
negative association between blood glucose and EI in all
subjects. These results suggest that insulin, but not glucose,
is associated with short-term appetite regulation in healthy
subjects but that the relationship is disrupted in overweight
and obese subjects. The authors concluded that the post-
prandial insulin response may be an important satiety
signal and that central nervous system IR in overweight
might explain the blunted effects on appetite. Hence, the
results of this study do not support a significant role for
blood glucose in short-term appetite regulation, a finding
supported by other studies (34–36). However, it has been
proposed that the potential effect of insulin as a satiety
signal might require raised blood glucose concentrations
(37). Hence, the presence of both hyperinsulinaemia and
hyperglycaemia (or an interaction between the two) may be
required to inhibit appetite and food intake. Further studies
are also required to clarify how insulin and the incretin
hormones (glucose-dependant insulinotropic polypeptide
[GIP] and glucagon-like peptide-1 [GLP-1]) interact in the
regulation of appetite.
Postprandial glycaemia and body weight
control: evidence from long-term dietary
intervention studies
Long-term effects of GI interventions on postprandial
glycaemia and body weight control
Table 2 summarizes the findings from the available long-
term studies of the effects of GI interventions on body
weight control in healthy participants. Raben (17) reviewed
20 longer-term studies (<6 months duration) of the effects
of LGI or HGI on body weight (see Table 2 for study
details). Eighteen of these studies used weight maintenance
(isoenergetic) or weight-loss (energy restricted) diets, and
the remaining 2 longer-term studies used ad libitum diets.
Taken together, the results of the 20 longer-term studies
reviewed by Raben revealed a greater weight loss on an LGI
diet in 4 studies, a greater weight loss on an HGI diet in 2
studies and no differences in weight loss between these diets
in 14 studies. The mean weight change across all 20 studies
was -1.5 kg on an LGI diet and -1.6 kg on an HGI diet.
When focusing only on the nine studies where energy and
macronutrient content were similar, one study found a
obesity reviews Postprandial glycaemia and health E. E. Blaak et al. 929
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity 13, 923–984, October 2012
Ta
bl
e
2
Lo
ng
-t
er
m
hu
m
an
in
te
rv
en
tio
n
st
ud
ie
s
ex
am
in
in
g
th
e
ef
fe
ct
of
G
I
in
te
rv
en
tio
ns
on
b
od
y
w
ei
g
ht
co
nt
ro
li
n
he
al
th
y
p
ar
tic
ip
an
ts
R
ef
er
en
ce
S
ub
je
ct
s
D
ur
at
io
n
D
ie
ta
ry
in
te
ve
nt
io
n
E
ffe
ct
s
on
b
od
y
w
ei
g
ht
C
on
cl
us
io
n
R
ab
en
A
.,
(2
00
2)
(1
7)
R
ev
ie
w
p
ap
er
20
st
ud
ie
s
in
cl
ud
ed
M
an
d
F;
nw
,
ow
an
d
ob
6
d
–6
m
on
th
s
LG
I
fo
od
s/
d
ie
ts
vs
.
H
G
I
fo
od
s/
d
ie
ts
(1
8
st
ud
ie
s)
or
LG
I
vs
.
re
d
uc
ed
-f
at
d
ie
t
(2
st
ud
ie
s)
A
cr
os
s
20
st
ud
ie
s,
m
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
1.
5
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
1.
6
kg
.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
LG
I
–
4
st
ud
ie
s.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
H
G
I
–
2
st
ud
ie
s.
N
o
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
–
14
st
ud
ie
s.
In
9/
20
st
ud
ie
s
w
he
re
d
ie
ts
w
er
e
si
m
ila
r
in
en
er
g
y,
m
ac
ro
nu
tr
ie
nt
an
d
fib
re
,
m
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
3.
0
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
2.
8
kg
.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
LG
I
–
1
st
ud
y.
N
o
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
–
8
st
ud
ie
s.
(1
)
Is
oe
ne
rg
et
ic
d
ie
ts
(n
=
13
):
M
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
0.
2
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
0.
7
kg
.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
LG
I
–
2
st
ud
ie
s.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
H
G
I
–
1
st
ud
y.
N
o
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
–
10
st
ud
ie
s.
In
6/
13
st
ud
ie
s
w
he
re
d
ie
ts
w
er
e
si
m
ila
r
in
en
er
g
y,
m
ac
ro
nu
tr
ie
nt
an
d
fib
re
th
er
e
w
er
e
no
d
iff
er
en
ce
s
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I.
M
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
0.
8
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
0.
7
kg
.
(2
)
E
ne
rg
y-
re
st
ric
te
d
d
ie
ts
(n
=
5)
:
m
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
4.
8
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
3.
3
kg
.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
LG
I
–
2
st
ud
ie
s.
N
o
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
–
3
st
ud
ie
s.
In
3/
5
st
ud
ie
s
w
he
re
d
ie
ts
w
er
e
si
m
ila
r
in
en
er
g
y,
m
ac
ro
nu
tr
ie
nt
an
d
fib
re
,
1s
tu
d
y
sh
ow
ed
a
g
re
at
er
w
ei
g
ht
lo
ss
w
ith
LG
I,
b
ut
th
er
e
w
er
e
no
d
iff
er
en
ce
s
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
in
te
rv
en
tio
ns
in
2
st
ud
ie
s.
M
ea
n
w
ei
g
ht
lo
ss
w
ith
LG
I=
6.
2
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
4.
8
kg
.
(3
)
A
d
lib
itu
m
d
ie
ts
(n
=
2)
:
m
ea
n
w
ei
g
ht
ch
an
g
e
w
ith
LG
I=
+0
.4
kg
;
m
ea
n
w
ei
g
ht
lo
ss
on
H
G
I=
0.
5
kg
.
G
re
at
er
w
ei
g
ht
lo
ss
w
ith
H
G
I
–
1
st
ud
y
(R
ab
en
et
al
.
19
97
[4
2]
)
N
o
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
–
1
st
ud
y
(B
ou
ch
e
et
al
.
20
02
[3
9]
).
N
o
ev
id
en
ce
th
at
LG
I
fo
od
s
ar
e
su
p
er
io
r
to
H
G
I
fo
od
s
w
ith
re
sp
ec
t
to
lo
ng
-t
er
m
b
od
y
w
ei
g
ht
co
nt
ro
l.
Fu
rt
he
r
w
or
k
ne
ed
ed
w
ith
ad
lib
itu
m
in
ta
ke
of
d
ie
ts
si
m
ila
r
in
al
la
sp
ec
ts
ex
ce
p
t
G
I.
930 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity13, 923–984, October 2012
Ta
bl
e
2
C
on
tin
ue
d
R
ef
er
en
ce
S
ub
je
ct
s
D
ur
at
io
n
D
ie
ta
ry
in
te
ve
nt
io
n
E
ffe
ct
s
on
b
od
y
w
ei
g
ht
C
on
cl
us
io
n
B
or
ne
t
F.
R
.
et
al
.
(2
00
7)
(1
9)
R
ev
ie
w
p
ap
er
7
st
ud
ie
s
in
cl
ud
in
g
a
to
ta
lo
f
61
he
al
th
y
nw
an
d
22
5
ow
or
ob
su
b
je
ct
s
8
d
–4
m
on
th
s
A
d
lib
itu
m
LG
I
vs
.
H
G
I
d
ie
ts
w
ith
si
m
ila
r
m
ac
ro
nu
tr
ie
nt
co
m
p
os
iti
on
6/
7
st
ud
ie
s
m
ea
su
re
d
b
od
y
w
ei
g
ht
ch
an
g
e.
3/
7
st
ud
ie
s
(B
ou
ch
e
et
al
.
20
02
[3
9]
;
B
ry
ne
s
et
al
.
20
03
[4
0]
;
S
lo
th
et
al
.
20
04
[4
1]
)
sh
ow
ed
a
no
n-
si
g
ni
fic
an
t
te
nd
en
cy
fo
r
LG
I
d
ie
ts
to
d
ec
re
as
e
ad
lib
itu
m
E
I
re
la
tiv
e
to
H
G
I
d
ie
ts
b
ut
no
si
g
ni
fic
an
t
d
iff
er
en
ce
in
b
od
y
w
ei
g
ht
ch
an
g
e.
4/
7
st
ud
ie
s
d
id
no
t
d
em
on
st
ra
te
a
re
d
uc
tio
n
in
ad
lib
itu
m
E
I
w
ith
LG
I
d
ie
ts
co
m
p
ar
ed
w
ith
H
G
I
d
ie
ts
.
O
f
th
e
3
st
ud
ie
s
th
at
m
ea
su
re
d
b
od
y
w
ei
g
ht
ch
an
g
e,
1
st
ud
y
(M
cM
ill
an
-P
ric
e
et
al
.
20
06
[4
4]
)
re
p
or
te
d
w
ei
g
ht
lo
ss
on
b
ot
h
th
e
LG
I
an
d
th
e
H
G
I
d
ie
ts
(P
=
0.
9)
,
1
st
ud
y
(W
ol
ev
er
&
M
eh
lin
g
20
03
[4
5]
)
re
p
or
te
d
g
re
at
er
w
ei
g
ht
lo
ss
on
th
e
H
G
I
(0
.4
9
kg
)
th
an
th
e
LG
I
d
ie
t
(0
.1
9
kg
)
an
d
th
e
ot
he
r
st
ud
y
(R
ab
en
et
al
.
19
97
[4
2]
)
re
p
or
te
d
si
g
ni
fic
an
t
w
ei
g
ht
lo
ss
on
th
e
H
G
I
d
ie
t
(0
.7
kg
)
b
ut
no
w
ei
g
ht
ch
an
g
e
on
th
e
LG
I
d
ie
t.
B
ec
au
se
of
th
e
in
cr
ea
si
ng
nu
m
b
er
of
co
nf
ou
nd
in
g
va
ria
b
le
s
in
th
e
av
ai
la
b
le
lo
ng
-t
er
m
st
ud
ie
s,
th
e
au
th
or
s
st
at
e
th
at
it
is
no
t
p
os
si
b
le
to
co
nc
lu
d
e
th
at
LG
I
d
ie
ts
m
ed
ia
te
a
he
al
th
b
en
efi
t
b
as
ed
on
b
od
y
w
ei
g
ht
re
g
ul
at
io
n.
Th
e
au
th
or
s
no
te
a
la
ck
of
lo
ng
-t
er
m
,
w
el
l-p
ow
er
ed
st
ud
ie
s
w
ith
w
el
l-c
on
tro
lle
d
d
ie
ts
d
iff
er
in
g
on
ly
in
G
I.
Th
om
as
D
.
et
al
.
(2
00
7)
(4
6)
S
ys
te
m
at
ic
R
es
ea
rc
h
R
ev
ie
w
6
R
C
Ts
in
cl
ud
in
g
a
to
ta
lo
f
20
2
M
an
d
p
re
d
om
in
an
tly
F
w
ho
w
er
e
ow
or
ob
.
M
ea
n
ag
e
ra
ng
ed
fro
m
16
to
46
ye
ar
s.
5
w
ee
ks
–6
m
on
th
s
3
st
ud
ie
s:
LG
I
vs
.
H
G
I
d
ie
t.
1
st
ud
y:
ad
lib
itu
m
re
d
uc
ed
G
L
vs
.
en
er
g
y
re
st
ric
te
d
lo
w
fa
t.
1
st
ud
y:
en
er
g
y-
re
st
ric
te
d
LG
I
vs
.
no
rm
al
en
er
g
y-
re
st
ric
te
d
d
ie
t.
1
st
ud
y:
ad
lib
itu
m
LG
I
d
ie
t
vs
.
en
er
g
y-
re
st
ric
te
d
lo
w
-f
at
d
ie
t.
5
st
ud
ie
s
m
ea
su
re
d
b
od
y
w
ei
g
ht
ch
an
g
e
(B
ou
ch
e
et
al
.
20
02
[3
9]
;
E
b
b
el
in
g
et
al
.
20
05
[4
8]
;
M
cM
ill
an
-P
ric
e
et
al
.
20
06
[4
4]
;
S
la
b
b
er
et
al
.
19
94
[4
9]
;
S
lo
th
et
al
.
20
04
[4
1]
).
2
st
ud
ie
s
m
ea
su
re
d
ch
an
g
e
in
B
M
I
ch
an
g
e
(E
b
b
el
in
g
et
al
.
20
03
[4
7]
;
S
la
b
b
er
et
al
.
19
94
[4
9]
).
P
oo
le
d
d
at
a
fro
m
4
st
ud
ie
s
re
p
or
tin
g
ab
so
lu
te
(k
g
)
b
od
y
w
ei
g
ht
ch
an
g
e
sh
ow
ed
th
at
w
ei
g
ht
lo
ss
w
as
si
g
ni
fic
an
tly
g
re
at
er
in
su
b
je
ct
s
re
ce
iv
in
g
th
e
LG
d
ie
t
co
m
p
ar
ed
w
ith
th
os
e
re
ce
iv
in
g
th
e
co
m
p
ar
is
on
d
ie
t
(-
1.
1
kg
,
P
<
0.
05
).
O
ne
st
ud
y
(E
b
b
el
in
g
et
al
.
20
05
[4
8]
)
re
p
or
te
d
%
ch
an
g
e
in
b
od
y
w
ei
g
ht
.
%
w
ei
g
ht
lo
ss
w
as
8.
4%
in
th
e
LG
I
an
d
7.
8%
in
th
e
co
nv
en
tio
na
ld
ie
t
g
ro
up
re
sp
ec
tiv
el
y.
Th
e
d
ec
re
as
e
in
B
M
I
w
as
g
re
at
er
in
su
b
je
ct
s
re
ce
iv
in
g
th
e
LG
I
d
ie
t
co
m
p
ar
ed
to
th
e
co
m
p
ar
at
or
d
ie
t
(-
1.
3
B
M
I
un
its
,
P
<
0.
05
).
O
w
or
ob
es
e
su
b
je
ct
s
on
LG
I
d
ie
ts
lo
st
m
or
e
w
ei
g
ht
th
an
th
os
e
on
H
G
I
or
co
nv
en
tio
na
le
ne
rg
y-
re
st
ric
te
d
w
ei
g
ht
lo
ss
d
ie
ts
.
It
m
ay
b
e
ea
si
er
to
ad
he
re
to
an
LG
I
d
ie
t
th
an
a
co
nv
en
tio
na
lw
ei
g
ht
lo
ss
d
ie
t
b
ec
au
se
th
er
e
is
le
ss
ne
ed
to
re
st
ric
t
in
ta
ke
of
fo
od
as
lo
ng
as
LG
I
C
H
O
s
ar
e
p
re
d
om
in
an
tly
co
ns
um
ed
.
Lo
w
er
in
g
th
e
LG
I
of
fo
od
s
in
th
e
d
ie
t
ap
p
ea
rs
to
b
e
an
ef
fe
ct
iv
e
m
et
ho
d
of
lo
si
ng
w
ei
g
ht
,
p
ar
tic
ul
ar
ly
fo
r
th
e
ob
es
e.
A
st
on
L.
et
al
.
(2
00
8)
(5
6)
19
su
b
je
ct
s
F,
ow
an
d
ob
A
g
e
34
–6
5
ye
ar
s
12
w
ee
ks
In
co
rp
or
at
io
n
of
LG
I
or
H
G
I
fo
od
s
in
to
th
e
ha
b
itu
al
d
ie
t.
O
ve
ra
ll
G
I
of
64
vs
.
56
.
N
o
d
iff
er
en
ce
s
in
E
I,
b
od
y
w
ei
g
ht
or
b
od
y
co
m
p
os
iti
on
b
et
w
ee
n
tre
at
m
en
ts
N
o
ev
id
en
ce
to
su
p
p
or
t
an
ef
fe
ct
of
a
re
d
uc
ed
G
I
d
ie
t
on
sa
tie
ty
,
E
I
or
b
od
y
w
ei
g
ht
in
ow
/o
b
F.
C
la
im
s
th
at
G
I
m
ay
ha
ve
sp
ec
ifi
c
ef
fe
ct
s
on
b
od
y
w
ei
g
ht
m
ay
b
e
m
is
le
ad
in
g
.
obesity reviews Postprandial glycaemia and health E. E. Blaak et al. 931
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity 13, 923–984, October 2012
Ta
bl
e
2
C
on
tin
ue
d
R
ef
er
en
ce
S
ub
je
ct
s
D
ur
at
io
n
D
ie
ta
ry
in
te
ve
nt
io
n
E
ffe
ct
s
on
b
od
y
w
ei
g
ht
C
on
cl
us
io
n
B
el
lis
le
F.
et
al
.
(2
00
7)
(5
7)
A
g
e
>
18
ye
ar
s
B
M
I>
25
kg
m
-2
12
w
ee
ks
W
ei
g
ht
W
at
ch
er
s
P
oi
nt
s
sy
st
em
w
ith
LG
I
vs
.
H
G
I
ch
oi
ce
s
N
o
si
g
ni
fic
an
t
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
LG
I
an
d
H
G
I
in
te
rv
en
tio
n
N
o
ef
fe
ct
of
en
co
ur
ag
in
g
co
ns
um
p
tio
n
of
LG
I
p
ro
d
uc
ts
on
w
ei
g
ht
or
fa
t
m
as
s
D
as
S
.K
.
et
al
.
(2
00
7)
(5
8)
C
A
LE
R
IE
tr
ia
l
24
ow
M
an
d
F
20
–4
2
ye
ar
s
12
m
on
th
s
R
C
T
of
H
G
L
(G
I
86
)
an
d
LG
L
(G
I
52
)
en
er
g
y-
re
st
ric
te
d
d
ie
ts
.
A
ll
fo
od
p
ro
vi
d
ed
fo
r
6
m
on
th
s
p
lu
s
6
m
on
th
s
se
lf-
ad
m
in
is
te
re
d
.
N
o
si
g
ni
fic
an
t
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
th
e
H
G
L/
H
G
I
an
d
LG
L/
LG
I
in
te
rv
en
tio
ns
(u
p
to
12
m
on
th
s)
E
ne
rg
y-
re
st
ric
te
d
d
ie
ts
d
iff
er
in
g
su
b
st
an
tia
lly
in
G
L/
G
I
in
d
uc
e
co
m
p
ar
ab
le
lo
ng
-t
er
m
w
ei
g
ht
lo
ss
.
S
ug
g
es
ts
th
at
a
b
ro
ad
ra
ng
e
of
he
al
th
y
d
ie
ts
ca
n
su
cc
es
sf
ul
ly
p
ro
m
ot
e
w
ei
g
ht
lo
ss
.
D
e
R
ou
g
em
on
t
A
.
et
al
.
(2
00
7)
(5
9)
O
w
20
–6
0
ye
ar
s
5
w
ee
ks
A
d
lib
iu
tm
H
G
L/
H
G
I
vs
.
LG
L/
LG
I
d
ie
ts
H
G
I/H
G
L
d
ie
t:
w
ei
g
ht
lo
ss
=
0.
2
kg
LG
I/L
G
L
d
ie
t:
w
ei
g
ht
lo
ss
=
1.
1
kg
S
ig
ni
fic
an
tly
d
iff
er
en
t
(P
<
0.
04
)
M
or
e
b
od
y
w
ei
g
ht
an
d
fa
t
lo
ss
w
ith
th
e
LG
L/
LG
I
d
ie
t
E
b
b
el
in
g
C
.B
.
et
al
.
(2
00
7)
(6
0)
O
b
18
–3
5
ye
ar
s
6
m
on
th
s
A
d
lib
iu
tm
H
G
L/
H
G
I
vs
.
LG
L/
LG
I
d
ie
ts
N
o
si
g
ni
fic
an
t
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
th
e
H
G
L/
H
G
I
an
d
LG
L/
LG
I
in
te
rv
en
tio
ns
.
A
ls
o
no
si
g
ni
fic
an
t
d
iff
er
en
ce
at
12
-
an
d
18
-m
on
th
fo
llo
w
-u
p
.
N
o
su
p
er
io
r
ef
fe
ct
of
th
e
LG
L/
LG
I
d
ie
t
in
te
rm
s
of
b
od
y
w
ei
g
ht
lo
ss
.
H
ow
ev
er
,
m
or
e
p
ro
no
un
ce
d
w
ei
g
ht
an
d
fa
t
lo
ss
in
su
b
je
ct
s
w
ith
hi
g
h
in
su
lin
re
sp
on
se
at
30
m
in
or
al
g
lu
co
se
to
le
ra
nc
e
te
st
.
M
ak
iK
.C
.
et
al
.
(2
00
7)
(6
1)
M
an
d
F
18
–6
5
ye
ar
s
H
ig
h
w
ai
st
ci
rc
um
fe
re
nc
e

87
cm
F

90
cm
M
12
w
ee
ks
w
ei
g
ht
lo
ss
th
en
24
w
ee
ks
w
ei
g
ht
m
ai
nt
en
an
ce
H
G
L/
lo
w
fa
t
en
er
g
y
re
st
ric
te
d
vs
.
LG
L
ad
lib
itu
m
LG
L
ad
lib
itu
m
g
ro
up
lo
st
m
or
e
w
ei
g
ht
th
an
H
G
L/
lo
w
-f
at
g
ro
up
at
12
w
ee
ks
(-
4.
9
vs
.
-2
.5
kg
,
P
=
0.
00
2)
,
b
ut
th
e
2
g
ro
up
s
d
id
no
t
d
iff
er
at
w
ee
k
36
.
LG
L
ad
lib
itu
m
g
ro
up
lo
st
m
or
e
fa
t
m
as
s
th
an
H
G
L/
lo
w
-f
at
g
ro
up
at
12
w
ee
ks
(-
1.
9
vs
.
-0
.9
kg
,
P
=
0.
01
6)
,
b
ut
th
e
2
g
ro
up
s
d
id
no
t
d
iff
er
at
w
ee
k
36
.
A
n
ad
lib
itu
m
re
d
uc
ed
G
L
d
ie
t
is
a
re
as
on
ab
le
al
te
rn
at
iv
e
to
a
lo
w
-f
at
p
or
tio
n
co
nt
ro
lle
d
w
ei
g
ht
lo
ss
d
ie
t,
b
ut
m
or
e
ev
id
en
ce
is
ne
ed
ed
to
d
et
er
m
in
e
st
ra
te
g
ie
s
to
im
p
ro
ve
w
ei
g
ht
lo
ss
m
ai
nt
en
an
ce
.
S
ic
hi
er
iR
.
et
al
.
(2
00
7)
(6
2)
20
3
he
al
th
y
F
B
M
I
23
–3
0
kg
m
-2
25
–4
5y
ea
rs
18
m
on
th
s
LG
I
vs
.
H
G
I
en
er
g
y-
re
st
ric
te
d
d
ie
t
N
o
si
g
ni
fic
an
t
d
iff
er
en
ce
in
w
ei
g
ht
lo
ss
b
et
w
ee
n
th
e
H
G
I
an
d
/L
G
I
in
te
rv
en
tio
ns
at
6,
12
or
18
m
on
th
s.
R
es
ul
ts
d
o
no
t
su
p
p
or
t
th
e
hy
p
ot
he
si
s
th
at
LG
I
d
ie
ts
en
ha
nc
e
w
ei
g
ht
lo
ss
su
cc
es
s.
S
ug
g
es
tio
n
th
at
LG
I
d
ie
ts
w
ou
ld
b
e
su
cc
es
sf
ul
fo
r
w
ei
g
ht
co
nt
ro
li
n
in
su
lin
-r
es
is
ta
nt
in
d
iv
id
ua
ls
b
ut
m
or
e
w
or
k
ne
ed
ed
.
B
M
I,
b
od
y
m
as
s
in
d
ex
;
C
H
O
,
ca
rb
oh
yd
ra
te
;
E
I,
en
er
g
y
in
ta
ke
;
F,
fe
m
al
e;
G
I,
g
ly
ca
em
ic
in
d
ex
;
G
L,
g
ly
ca
em
ic
lo
ad
;
H
G
I,
hi
g
h
g
ly
ca
em
ic
in
d
ex
;
H
G
L,
hi
g
h
g
ly
ca
em
ic
lo
ad
;
LG
I,
lo
w
g
ly
ca
em
ic
in
d
ex
;
LG
L,
lo
w
g
ly
ca
em
ic
lo
ad
;
M
,
m
al
e;
nw
,
no
rm
al
w
ei
g
ht
;
ob
,
ob
es
e;
ow
,
ov
er
w
ei
g
ht
;
R
C
T,
ra
nd
om
iz
ed
co
nt
ro
lle
d
tr
ia
l.
932 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity13, 923–984, October 2012
decrease in body weight on an LGI diet vs. an HGI diet, but
the other eight studies did not. Raben (38) concluded that
LGI diets were not superior to HGI diets with respect to
long-term body weight control but that the optimal study
with ad libitum EI on diets matched in all aspects except GI
(e.g. macronutrients, fibre, energy density, food form) is
still to be performed.
Bornet and colleagues (19) argue that only ad libitum
diet design studies are relevant for evaluating the effect of
LGI vs. HGI diets on spontaneous long-term regulation of
EI and body weight. Consequently in their review, the
only long-term studies that were selected for analysis were
those in which LGI and HGI diets were consumed ad
libitum. In addition, only studies for which the propor-
tion of macronutrients was similar between the LGI and
HGI diets were retained for final analysis in order to
take into account the known different satiating capacities
between macronutrients. Bornet and colleagues identified
seven longer-term studies meeting the above selection cri-
teria (two of which were included in Raben’s review; see
Table 2 for study details). Three of these studies (39–41)
demonstrated a non-significant tendency of LGI diets to
induce a decrease in ad libitum EI compared with HGI
diets with no significant difference in body weight change.
In the four remaining ad libitum diet studies identified by
Bornet and colleagues (19), the LGI diets did not reduce
EI relative to the HGI diets (42–45). Bornet and col-
leagues concluded that while there was some evidence
from short-term studies that low-glycaemic foods (LGI in
particular) possessed greater satiating properties than
high-glycaemic foods, the available long-term studies did
not allow a conclusion about the regulation of body
weight and that more long-term, well-powered studies
with well-controlled diets differing only in GI were
needed.
Thomas and colleagues (46) conducted a systematic
review of the effects of LGI or low glycaemic load (LGL)
diets on weight loss in healthy overweight or obese people.
Randomized controlled trials (RCTs) comparing an LGI or
an LGL diet with a higher GI or GL diet or other control diet
(Cdiet) in overweight or obese participants were selected for
inclusion. The authors identified six RCTs meeting their
inclusion criteria with interventions varying from5weeks to
6 months duration with up to 6 months follow-up after the
intervention period. Three of the studies identified by
Thomas and colleagues were also included in the review
by Bornet and colleagues (39,41,44). Thomas and col-
leagues also identified additional studies by Ebbeling and
co-workers (47,48) and Slabber and co-workers (49).
Thomas and colleagues (46) found that the decrease in
body mass, total fat mass and BMI, total cholesterol and
low-density lipoprotein (LDL)-cholesterol was significantly
greater in healthy overweight and obese subjects receiving
the LGI compared with Cdiets (including HGI or high
glycaemic load [HGL] diets and conventional energy-
restricted, low-fat weight-loss diets) even when the diets
were ad libitum. Of the six studies included in this review,
two studies included obese participants (47,49) and com-
pared LGI or LGL diets with conventional weight-reducing
low-fat diets. The remaining four studies included partici-
pants with borderline normal weight (BMI = 25) or over-
weight (BMI of 26–30) and compared an LGI or an LGL
diet with a higher GI or GL diet. Only one study involved
children (47). In the two studies where all the subjects were
obese, the effects of the LGI or LGL diets were more
apparent. Hence, the authors concluded that lowering the
GI of foods in the diet appears to be an effective method of
losing weight, particularly for the obese. However, Thomas
and colleagues (46) do acknowledge that the major
challenge in weight management is the sustainability of
weight loss or the maintenance of body weight. Conse-
quently they concede that longer trials with increased
lengths of follow-up (>6 months) are needed to determine if
the improvements reported with LGI diets can be main-
tained and incorporated into lifestyle long-term.
Hare-Bruun et al. (50) have examined the epidemiologi-
cal evidence linking GI and GL to heart disease, insulin
sensitivity (T2DM) and obesity among initially healthy
people. The observational studies of associations between
GI and BMI, body weight or body composition were pri-
marily cross-sectional and conducted among adults. The
authors found that the evidence for associations between
GI, and particularly GL, and health (taking into account
the magnitude of obesity) among free-living populations is
mixed. These results contrast with those of Thomas et al.
(46) and also Livesey et al. (51,52), who observed reduc-
tions in body weight on both LGI and LGL diets. However,
a major difference between these two reviews and the
review by Hare-Bruun and colleagues was the focus on
treatment studies and hence weight loss among overweight
and obese people in the meta-analyses. Furthermore, the
review by Livesey and colleagues included studies in
subjects with type 1 diabtes mellitus (T1DM) or T2DM,
impaired glucose tolerance (IGT), hyperlipidaemia and
coronary heart disease (CHD) risk. Instead, the studies
reviewed by Hare-Bruun and colleagues focused on the
prevention of weight gain and reported on the associations
between the GI and GL of the habitual diet and weight
change over longer time periods.
As the evidence from their review was not strong, Hare-
Bruun et al. (50) concluded that it seems premature to
include GI in the dietary recommendations for healthy
populations. They also argue that it may be difficult for
individuals to apply the GI concept to the usual diet as this
requires some nutritional knowledge or at least a dedicated
effort to learn how to use it in practice. In response to this
type of concern, Pawlak and colleagues (53) have empha-
sized that several studies have reported significant improve-
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ment in relevant end points among subjects consuming
self-selected LGI diets. Moreover, LGI diets not only facili-
tated glycaemic control but were also perceived as ‘simple
and practical’ by adults and children with newly diagnosed
diabetes (54,55).
The meta-analysis published by Livesey and colleagues
(51,52) included controlled GI intervention studies pub-
lished until 2005. Since then, several additional RCTs
on GI/GL in healthy overweight or obese subjects have
been published (56–62). The difference in weight loss
observed between the high- or LGI/GL diets across these
studies ranged from 0.5 kg (57) to -1.9 kg (61) and was
statistically significant in only one study (59). In a review
on sugar consumption and body weight, which included
these new studies, Van Baak & Astrup (63) conclude that
any effect of LGI/GL diets on body weight appears to be
small and is, therefore, of limited practical and clinical
importance.
More recently, data from the large-scale intervention
study on Diet, Obesity and Genes (Diogenes) (64–66)
(http://www.diogenes-eu.org) have become available. In
the Diogenes study, overweight adults from eight Euro-
pean countries who had lost at least 8% of their body
weight on an 800-kcal low-calorie diet (LCD) were ran-
domized to one of five ad libitum diets to prevent weight
regain over a 26-week period. Maintenance diets were
either high or low in protein and GI according to a two-
by-two factorial design or a Cdiet (following the dietary
guidelines in each participating country). The recently
published results demonstrate that both the rate of
completion of the dietary intervention phase and the
maintenance of weight loss were highest in participants
assigned to the high-protein (HP) diets and to the LGI
diets. In addition, participants assigned to the HP/LGI diet
continued to lose weight after the LCD weight loss phase
(65). Hence, in this study, a modest increase in protein
content and a modest reduction in GI led to an improve-
ment in study completion and maintenance of weight loss,
suggesting that an HP/LGI diet is best for weight mainte-
nance after weight loss.
Effects of other dietary factors on postprandial
glycaemia in both the short- and the long-term
Although many studies have been performed with variable
results, many are confounded by dietary differences in the
diets other than glycaemic response alone (energy, macro-
nutrient and fibre content) and as such are difficult to
interpret. Three well-controlled studies matching both
macronutrients and fibre (Bouche et al. [39] 5 weeks;
Sloth et al. [41] 10 weeks; Sichieri et al. [62] 18 months)
found no change in body weight or body fat mass. In
addition, Aston et al. (56) performed an RCT in over-
weight and obese women, measuring the effect of a higher
vs. a lower GI ad libitum diet on appetite, dietary intake
and body weight using a cross-over design (12 weeks on
each diet). The diets were matched for energy, macronu-
trient and fibre intakes, but no differences were found
between the higher and lower GI diets for any of the end
points measured. These findings indicate that the differ-
ence in appetite and body weight sometimes observed
after the consumption of LGI foods relative to HGI foods
is due to factors other than the difference in blood glucose
(27,32). Based on her review of the relevant literature,
Raben (17) argues that postprandial glycaemia and appe-
tite are not related. Peters and colleagues suggest that
inconsistencies between studies examining the effects of GI
on appetite might be explained by a lower-than-expected
carbohydrate energy availability or by other (physical
and nutritional) food properties differing between test
products (43).
In addition to the quantity and digestibility of starches
and the quantity and sources of sugars in a meal, many
other factors influence the glycaemic response to foods.
These include the presence of fat and protein, the degree of
processing and cooking, and the amount and types of
dietary fibre present. Indeed, it is often not possible to
distinguish the effects of lowering postprandial glycaemia
per se from the known effects of certain dietary fibres on
appetite and body weight (67,68). A number of mecha-
nisms have been suggested to account for the beneficial
effects of certain fibres on appetite and weight control.
These mechanisms could be due to an action in the mouth,
stomach or intestines. Specific soluble fibres in particular
could increase the viscosity of the diet and slow down
digestion, thus stimulating the release of satiety peptides.
Some fibres could also act as a mechanical barrier to the
digestion of other macronutrients, leading to blunted
glucose and insulin responses. Additionally, fermentation
products of certain fibres in the large intestine, including
specific short-chain fatty acids (SCFAs), may exert a late
action on satiety.
It is generally accepted that adding fat and/or protein
to carbohydrate reduces blood glucose levels compared
with carbohydrate alone (69). Co-ingestion of fat with
carbohydrate slows gastric emptying and thus the release
of glucose into the blood, ultimately lowering the GI.
Co-ingestion of protein with carbohydrate is also known
to reduce postprandial glycaemia (70–72). Milk proteins,
for example, reduce blood glucose responses when con-
sumed with carbohydrates (72) and are consistently found
to be insulinaemic. The exact mechanisms associated
with the glucose-lowering effects of fat and protein are
not clear, although they are suggested to occur through
similar mechanisms such as delayed gastric emptying (73)
and/or enhanced insulin secretion through augmented GIP
and GLP-1 secretion (74). However, fat and protein might
act to modulate the postprandial glucose response via dif-
ferent mechanisms. Hence, in one human study protein
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had a greater (two- to three-fold) hypoglycaemic action
than fat (75).
Postprandial glycaemia and substrate oxidation
It has been hypothesized that LGI foods may affect body
weight control and insulin sensitivity by promoting satiety
and stimulating fat oxidation at the expense of carbohy-
drate oxidation (8). Indeed, animal studies show that a
reduced GI can shift postprandial substrate use in favour
of fat oxidation, independent of diet-induced changes in
body composition or EI (76–78). It was recently shown
that a reduced glycaemic response after a mixed meal con-
taining isomaltulose (ISO) instead of sucrose (SUC) may
improve fat oxidation rates at the expense of carbohydrate
oxidation in overweight subjects (79). Similar findings
were also observed during exercise conditions (80). As
indicated above, this shift towards fat oxidation may be of
practical use for body weight control. A lower rate of
adaptation to a high-fat diet has been shown to lead
to weight gain over time, in particular with modern lif-
estyles incorporating a low level of physical activity (81).
Flatt (82) proposed that subjects who continue to oxidize
carbohydrate in the post-absorptive state deplete their
endogenous carbohydrate stores, thereby stimulating food
intake. This leads to increased food intake to replace
these diminished carbohydrate stores and increased fat
storage. Additionally, it has been hypothesized that a high
postprandial fat oxidation may inhibit food intake (83).
Through these mechanisms, inter-individual differences in
substrate selection may have an impact on energy balance
and may play a role in the development of obesity and
subsequently T2DM. Additionally, a shift towards a
greater postprandial fat oxidation may attenuate fat accu-
mulation in non-adipose tissues, leading to improved
insulin sensitivity (8).
Incretins and weight management
The incretin effect is the amplification of insulin secretion
when glucose is taken in orally as opposed to intravenously.
It is due to the combined actions of the incretin hormones:
GLP-1 and GIP (see also the role of incretins in the section
‘Prevention of diabetes and IR’). However, GLP-1 also
inhibits appetite and food intake in animals and humans
(84–86), and recent studies involving the GLP-1 receptor
antagonist exendin 9-39 have shown that GLP-1 is a physi-
ological regulator of appetite and food intake (87,88)
(Fig. 2). GLP-1 is encoded by the glucagon gene (GCG),
which also encodes oxyntomodulin, glucagon and GLP-2.
GLP-1 is synthesized in L-cells of the small intestine and is
released postprandially in proportion to EI. Carbohydrate
and fat seem to be especially effective stimuli for GLP-1
secretion (89). Native GLP-1 has a short elimination
half-life of 1–2 min because of dipeptidyl peptidase-4-
mediated degradation.
The dose-dependent inhibition of appetite by GLP-1
has been demonstrated in humans in a meta-analysis (90).
Clinical studies of GLP-1 mimetics (exenatide [91–96],
liraglutide [97–102], albiglutide [103] and taspoglutide
[104]) in overweight/obese patients with T2DM have dem-
onstrated significant and durable weight losses. Recent
studies with the long-acting GLP-1 analogue, liraglutide,
demonstrated dose-dependent weight losses exceeding
that obtained with the lipase inhibitor, orlistat, also in
non-diabetic obese individuals (63). In obese individuals,
endogenousGLP-1 responses tomeal intakemay be severely
reduced (86), suggesting that decreased GLP-1 levels may
contribute to the development of obesity, although its
appetite-suppressive potency appears to be preserved.
Figure 2 Glucagon-like peptide-1 (GLP-1) increase insulin secretion
lowers blood glucose and inhibits appetite.
The ingestion of food promotes the release of GLP-1 from L-cells in the
intestine, which activates vagal afferents. Activated GLP-1 neurons of
the nucleus of the solitary tract (NTS) project to the hypothalamic
arcuate nucleus (ARC), to modulate vagal motor outflow to the
pancreas and other tissues not depicted, increasing insulin secretion
from the b-cells in states of hyperglycaemia and suppresses glucagon
from the a-cells, leading to lowering of blood glucose. Systemic GLP-1
may also access the brain via leaks in the blood–brain barrier such as
the subfornical organ and the area postrema, as demonstrated to occur
in rats. In the brain, release of GLP-1 within the NTS and from
projections of GLP-1 neurons to the paraventricular neurons (PVN)
leads to GLP-1-R activation, which promotes satiety and anorexia.
Besides from the actions depicted in the picture GLP-1 has numerous
other actions including slowing gastric emptying and thereby flattening
glucose excursions, as well as cardiac effects.
Adapted from Torekov et al., Obesity Reviews 2011 (429), and Williams,
Endocrinology. 2009; 150: 2997–3001 (430).
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The other incretin hormone, GIP, does not have effects
on appetite and food intake but may have actions on the
adipose tissues, which express the GIP receptor. Knockout
of the GIP receptor prevents diet-induced obesity in mice
(105,106), and GIP may promote adipose tissue blood
flow and uptake of fatty acids and their incorporation in
triglycerides (TGs) (107,108). In contrast to GLP-1,
meal-stimulated GIP levels are frequently elevated in obese
individuals (109).
Nutrients affecting incretin secretion and
postprandial glycaemia
Because of the augmented secretion of the incretin hormones
and their effects on glucose-induced insulin responses,
healthy individuals can consume from25 to 100 g of glucose
without dose-related increases in plasma glucose. The incre-
tin effect ensures that up to 80% of ingested glucose (100 g)
is removed from the circulation and therefore does not
contribute to increased postprandial glycaemia (110). The
incretin hormones, therefore, play a very important role in
postprandial glycaemia. Up-regulation of the incretin effect
in response to increasing oral glucose loads seems to be
crucial for controlling glucose excursions in healthy sub-
jects. Patients with T2DM are characterized by an impaired
capability to regulate their incretin effect, which may con-
tribute to the exaggerated glucose excursions after oral
ingestion of glucose in these patients (111).
In a recent study with the GLP-1 receptor antagonist
exendin (9-39) amide, it was shown that GLP-1 released
after an oral meal lowers postprandial glycaemia. The inhi-
bition of glucagon release was a major determinant of the
acute GLP-1 action in healthy subjects (112). Another
study showed that the total GLP-1 AUC after a standard-
ized breakfast was higher following an evening meal com-
posed of barley bread compared with white wheat bread.
Correspondingly, the glucose AUC after a standardized
breakfast was higher following an evening meal composed
of white wheat bread compared with barley bread (113).
Thus, agents that enhance postprandial GLP-1 secretion
are likely to result in decreased postprandial glycaemia.
Because of the insulinotropic action of GLP-1 and GIP and
the associated importance of the incretins in glucose
homeostasis, much research has focused on the mecha-
nisms of carbohydrate sensing by GLP-1- and GIP-
producing cells. However, it is widely accepted that other
macronutrients can also stimulate hormone release from
these cells. Early studies indicated that protein was a rela-
tively weak stimulus for GIP and GLP-1 in humans,
although it probably contributed to the later phase of post-
prandial GLP-1 secretion (89). However, it has been shown
that the GIP response is accentuated when milk proteins are
delivered as peptide hydrolysates (114). Furthermore, daily
intake of either a soy supplement or placebo (casein) sig-
nificantly increases postprandial GIP response in the soy
group compared with the casein group (115). Fat ingestion
is widely considered a good stimulus for both GLP-1 and
GIP secretion. It has been shown that GLP-1 responses
were highest after an olive oil meal compared with a meal
with saturated fat (butter) (116,117). Although direct
exposure of the intestinal lumen to oleic acid did not
always result in significant stimulation of GLP-1 secretion
(118), the digestion of TGs to FFAs does seem a crucial
step, as inhibition of pancreatic lipase prevents the stimu-
lation of GIP and GLP-1 secretion. In the past few years,
lipid-sensing mechanisms have been dominated by the idea
that the newly discovered fatty-acid-sensitive G-protein-
coupled receptors underlie enteroendocrine responses to a
range of fatty acids and complex lipids. The mechanisms
employed to sense the arrival of carbohydrate, fat and
protein in the gut lumen have been investigated using organ
perfusion techniques, primary epithelial cultures and cell
line models. Furthermore, the current knowledge of the
molecular machinery underlying nutrient sensing within
GIP- and GLP-1-producing cells is covered in detail in the
reviews by Reimann (119) and Parker et al. (120) in 2010.
Another way in which GLP-1 regulates postprandial gly-
caemia is by inhibiting gastric emptying. With high physi-
ological doses of GLP-1 it is possible to completely arrest
gastric emptying for a couple of hours, and in clinical
studies with exenatide, postprandial glucose excursions are
flattened considerably (121).
In summary, up-regulation of the incretin effect in
response to increasing oral glucose loads seems to be
crucial for controlling glucose excursions and thereby post-
prandial glycaemia. Furthermore, recent evidence points to
a dual action of GLP-1, involved in both glucose homeo-
stasis and appetite regulation (Fig. 2).
Conclusions
Interest in the relationship between diet and health has
increased the demand for functional foods (foods with
specific beneficial properties beyond their basic nutritional
contribution). In particular, the obesity epidemic has
brought appetite control and nutrient partitioning to the
forefront of functions susceptible to modulation by foods
and food ingredients. Consequently, functional foods for
the control of appetite (and ultimately body weight) now
constitute a major health goal and research objective (122).
The belief that certain foods can help to control appetite
has led to a huge interest in identifying those properties of
foods that can influence food intake with knock-on benefits
for body weight control. These endeavours have resulted in
the popularity of the concept of ‘functional foods for
satiety and weight management’.
Some studies suggest that diets comprising foods that
elicit a lower postprandial glucose response may be useful
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as part of an overall strategy for combating obesity, but the
evidence for a role of postprandial glucose per se in these
effects is considerably weaker. Diets based on foods that
produce lower postprandial blood glucose responses (i.e.
LGI foods) reduce the risk of developing diabetes (123),
CVD (124) and certain cancers (125) while improving
insulin sensitivity, blood glucose control and blood lipid
profiles (126,127). There is also some evidence that LGI
diets stimulate fat oxidation at the expense of carbohydrate
oxidation (8) and reduce body fat deposition (8,128). The
mechanisms relating glycaemic response to the regulation
of body weight have been examined in controlled feeding
studies (129) and involve acute hormonal and metabolic
changes that may decrease hunger and EI. The biological
system underlying appetite control is becoming better
understood and involves close links between peripheral
physiology, metabolism and brain processes. It also embod-
ies mechanisms that are potential targets for foods designed
to influence satiety. Of particular interest, for example, are
gastro-intestinal peptides that are released following food
consumption and involved in the control of appetite and
satiety (cholecystokinin [CCK], GLP-1, peptide YY [PYY]
and ghrelin).
Although some short-term studies suggest that LGI car-
bohydrates suppress hunger more effectively than high-
GI carbohydrates, there is no strong mechanistic basis
for normal variation in postprandial blood glucose per se
(i.e. differences in blood glucose seen between typical high-
vs. LGI treatments) to affect appetite (34–36) and
ultimately body weight (38–41,43). Further, the known
satiating effect of insulin would generally argue for more
satiating effects of high-GI treatments and the studies
where nutritional composition is carefully controlled also
support this view. There are currently little data on the
effects of GI on body weight. Hence, there is a clear
need for more long-term well-designed human studies
to evaluate how high- and LGI diets (containing foods
of the same palatability, volume, energy density, macronu-
trient composition and fibre content) affect EI, body com-
position and body weight for biologically significant
periods of time. Indeed, recently published (2010) opinions
on dietary reference values (DRVs) for carbohydrates,
dietary fibre, fats and water adopted by EFSA’s Panel on
Dietetic Products, Nutrition and Allergies (130) include the
conclusion that evidence is still inconclusive on the role of
GI and GL in maintaining weight and preventing diet-
related diseases. In EFSA’s opinion, the currently available
long-term studies do not allow a reliable conclusion about
the regulation of EI and body weight because the food
constituents, carbohydrates that induce a low glycaemic
response and those with an LGI are not sufficiently char-
acterized. This is because the GI of a carbohydrate-
containing food depends on several factors other than the
amount of available (glycaemic) carbohydrates present.
Such factors include the amount and type of dietary fibre,
amount of dietary fat, physical properties, mode of prepa-
ration as well as individual factors (e.g. biological varia-
tion, rates and extent of digestion and absorption). In this
respect, more studies that specifically manipulate postpran-
dial glucose while quantifying the effects of this on satiety/
appetite and body weight are required. In conclusion,
unless a universal relationship between blood glucose
responses and satiety/appetite or other weight outcomes is
demonstrated, LGI diets or low glycaemic responses will
not assure enhanced satiety or weight management.
Postprandial glucose in relation to oxidative
stress and inflammation2
Introduction
Epidemiological studies support the evidence that post-
prandial (2 h) glucose is an independent predictor of CVD
and diabetes. Studies indicate that postprandial hypergly-
caemia contributes up to 70% of total daytime hypergly-
caemia. In T2DM, a positive correlation with HbA1c
concentration was reported for postprandial and prepran-
dial glucose concentrations (131). The contribution of
postprandial glucose in HbA1c concentration predomi-
nates in patients with fairly good control, whereas the
contribution of fasting hyperglycaemia increases as gly-
caemic control worsens (132). Many studies have
reported a stronger association of CVD risk and post-
prandial or postload glucose than for CVD risk and
HbA1c or mean blood glucose. However, HbA1c and
mean blood glucose show stronger associations with CVD
risk factors than do postprandial glycaemia or glucose
variability in people with diabetes (the A1C-Derived
Average Glucose [ADAG] study) (133). Also, specifically
targeting postprandial glucose by using prandial insulin
or meglitinides has not unequivocally resulted in improve-
ment of the CVD risk profile (134,135). Importantly,
there appears to be no glycaemic threshold for reduction
of either microvascular or macrovascular complications.
The progressive relationship between plasma glucose
and cardiovascular risk extends well below the diabetic
threshold (136,137). In this paragraph, both chronic and
acute hyperglycaemia in relation to oxidative stress and
inflammation will be addressed. Acute glucose variations
from peaks to nadirs include postprandial glucose excur-
sions that can be described by two components. The first
component, the duration of the postprandial glucose
increment, is a major contributor to chronic sustained
hyperglycaemia, while the second component, the magni-
tude of the postprandial rise, is more a reflection of
glucose variability. It is difficult to discriminate between
2The main authors of this section are Ellen Blaak and Michaela Diamant.
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the contributions of these two components of dysglycae-
mia. It seems that both contribute to the two main
mechanisms that lead to diabetic and cardiovascular com-
plications, namely excessive protein glycation and activa-
tion of oxidative stress.
Hyperglycaemia, elevated TGs/fatty acids and hyperin-
sulinaemia, which are particularly pronounced in the
postprandial state in individuals with IR and T2DM, are
abnormalities that often cluster, which makes it more
difficult to tease out and to study single effects. There
are indications that they may have distinct mechanisms of
action and, when present together, act synergistically to
induce oxidative stress, protein kinase C (PKC) activation
and advanced glycated end-product receptor (RAGE)
activation (138,139). Collectively, these derangements
promote inflammation, impaired endothelial function and
vascular disease (140,141). Besides, oxidative stress is not
only associated with the complications of obesity or diabe-
tes but has also been linked to IR in vitro and in vivo, both
major features of T2DM (142). To obtain a more detailed
understanding of the relationship between hyperglycaemia
(and related hyperlipidaemia and hyperinsulinaemia) and
oxidative stress and inflammatory responses, insight into
the underlying mechanisms might be of crucial importance.
Elevated glucose induces oxidative stress
and inflammation
There is now cogent evidence for a deleterious effect of
sustained chronic hyperglycaemia that results in excessive
protein glycation and generation of oxidative stress.
Notably, it is important to distinguish between hypergly-
caemia within the normal physiological range in normal
glucose-tolerant subjects and more pronounced excursions
in the impaired glucose-tolerant or diabetic state (143).
Intravenous glucose infusion in obese glucose-tolerant sub-
jects promotes oxidative stress, and it has been shown that
caloric restriction in obese subjects for a brief period of 4
weeks leads to a significant reduction of oxidative stress
(144). Also, glucose intake induces oxidative stress and
inflammation at cellular and molecular levels and, under
certain conditions, an acute increase in blood glucose is
associated with an acute inflammatory response. In vivo,
oral glucose challenges increase plasma levels of adhesion
factors (ICAM-1, VCAM-1 and e-selectin), cytokines
(interleukin [IL]-6, tumour necrosis factor alpha [TNFal-
pha]) and chemokines (IL-8) in healthy volunteers (145).
Finally, the consumption of a high-glycaemic meal
increases oxidative stress and reduces antioxidant defences,
with the increase being significantly greater with higher
levels of hyperglycaemia in young healthy volunteers (146).
Thus, as indicated above, glycaemic excursions within
the physiological range in healthy volunteers induce physi-
ologically significant effects on endothelial function, oxida-
tive stress and immune activation. Nevertheless, in normal
glucose-tolerant subjects these inflammatory responses
normalized within 2–3 h, while in obese impaired glucose-
tolerant and type 2 diabetic subjects, glucose-induced
inflammation was stronger or lasted longer, suggesting a
role for hyperglycaemia in immune activation (147–150).
Also in diabetic patients, after oral glucose and after
meals, reactive oxygen species (ROS) and/or LDL oxida-
tion was increased, indicating hyperglycaemia-induced
activation of oxidative stress (151). Several markers have
been used to assess oxidative stress and the antioxidant
status in patients with diabetes, including ox-LDL and
malondialdehyde (152). The short plasma half-life of these
markers is one of the limiting factors for the assessment of
oxidative stress in plasma samples. Thus, when available,
urinary measures provide a more reliable determination of
the activation of oxidative stress than plasma measure-
ments. From several studies, both in vitro and in vivo, there
is consistent evidence that hyperglycaemia is associated
with an increased urinary excretion rate of the oxidative
stress marker 8-iso-prostaglandin F2alpha. Ceriello (153)
showed that the production of free radicals was increased
in the postprandial period and that this increment was
proportional to the magnitude of postprandial glucose
excursions. Moreover, reductions of postmeal glucose
excursions induced by a premeal bolus of a rapid insulin
analogue resulted in decrements in glycaemia and nitroty-
rosine, a metabolite derived from nitrosamine stress
responses. Overall, numerous studies support the hypoth-
esis of a causal relationship between hyperglycaemia and
oxidative stress.
This seems consistent with findings that the metabolic
syndrome may support peripheral inflammation by sensi-
tizing leukocytes to up-regulate pro-inflammatory markers
in response to glucose, which in turn increases the risk for
T2DM and CVD (154).
Glucose fluctuations and the activation of
oxidative stress
The role of glucose variability from peaks to nadirs is less
well documented, but there are indications that postpran-
dial swings in glucose levels may increase oxidative stress.
In vitro studies do show a relationship between glycaemic
variability and oxidative stress-induced apoptosis and renal
cell proliferation in cultures human or rat cells, and these
findings are confirmed in an animal study (as reviewed by
Siegelaar et al. [155]).
Experimentally induced acute oscillations in glycaemia
resulted in greater increments in plasma concentrations
of some pro-inflammatory cytokines, such as IL-6, IL-18
and TNFalpha, than chronic hyperglycaemia in both
healthy and glucose-intolerant subjects (148). Also, glucose
at two different levels (10 and 15 mM) resulted in a
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concentration-dependent induction of both endothelial
dysfunction and oxidative stress in both normal and T2DM
patients, which seemed independent of the total amount of
glucose to which subjects are exposed. Vitamin C infusion
was shown to reverse hyperglycaemia-induced oxidative
stress endothelial dysfunction in normal subjects but
not in diabetic subjects. This suggests different underlying
mechanims in the two groups: one due to the actual level of
glycaemia and one due to the long-lasting damage induced
in the endothelial cells by chronic hyperglycaemia (156).
With respect to the design of the latter studies, the number
of consecutive periods with alternating degrees of glycae-
mia that are necessary to reliably assess glycaemic variabil-
ity can be debated. However, it may not be surprising that
these artificial repetitive elevations of blood glucose in nor-
moglycaemic individuals, that equalled glycaemic excur-
sions in T2DM patients, resulted in similar induction of
oxidative stress since blood glucose changes within the
normal range, which occur in the postprandial state in
normoglycaemic subjects, have been shown to raise
markers of oxidative stress (see the section ‘Elevated
glucose induces oxidative stress and inflammation’).
The results from cross-sectional studies investigating the
relationship between glucose variability, obtained from
continuous glucose monitoring (CGM), and oxidative stress
are, however, less consistent (155). Monnier et al. measured
24 h urinary excretion of 8-iso-prostagladins F2alpha
(8-iso-PGF2alpha), an indicator of free radical production,
and performed CGM in T2DM patients. There was a linear
correlation between increased free radical production
and the magnitude of glucose fluctuations (expressed as
MAGE), but not with the mean 24-h glucose concentration,
fasting plasma glucose or even HbA1c. 8-iso-PGF2alpha
concentrations were four times higher in patients with the
greatest as compared with patients having the lowest gly-
caemic variability (157,158). Furthermore, exposure of lean
non-diabetic subjects to the same magnitude of glycaemic
excursions, as reported by Monnier et al., doubled circulat-
ing nitrotyrosine concentrations (159).
However, a second study by Wentholt et al. (160)
addressing the same relationship in type 1 diabetic subjects
could not confirm the findings of Monnier. According to
the authors, this discrepancy was due to methodological
factors and differences in populations. Indeed, another
study using tandem mass spectrometry could not reproduce
a relationship between glucose variability and oxidative
stress (161). Also, a crossover trial comparing the effect of
a basal insulin regimen and a meal-time insulin regimen on
glucose variability and oxidative stress in T2DM patients
could not detect any differences in oxidative stress or any
correlation between glucose variability and 24-h excretion
rates of 8-iso-PGF2alpha (162). Thus, to date, the relation-
ship between glucose variability found in cell cultures and
animal studies has not been consistently reproduced in
human studies. Differences in methodology used for oxida-
tive stress quantification, as well as differences in the dura-
tion and frequency of periods with alternating glycaemia,
and populations may be possible explanations.
It has been hypothesized that repeated late postprandial
glucose concentrations below the fasting level induced by
carbohydrates with a high-glycaemic or insulinaemic index
could activate counter-regulatory stress hormones such
as cortisol and catecholamines. These hormones restore
fasting glucose concentrations and increase non-esterified
fatty acid concentrations but may also be involved in the
development of IR and metabolic complications. This is
supported by the finding that the modification of carbohy-
drate intake by replacing cereal products (oat and wheat
bread) with rye bread and pasta, which are characterized
by a low postprandial insulin response, differentially
modulates the mRNA expression of inflammatory markers
in both adipose tissue and circulating concentrations of
serum in men and women with metabolic syndrome, even
in the absence of weight loss (163). Indeed, after consuming
the wheat vs. the rye bread, glucose levels dropped below
fasting levels (average 6.3  0.7 mmol L-1) 3 h after meal
ingestion, whereas FFA increased concomitant to slightly
rising levels of inflammatory markers and epinephrine
(163). These data suggest that beside glycaemic variability,
the pattern of insulinaemic response may evoke differential
inflammatory and oxidative stress responses as well as
varying counterregulatory hormonal changes, all of which
may impact on diabetes and cardiovascular risk in the
long-term.
Tools for measuring glycaemic variability
Several approaches have been proposed, but for two main
reasons, all fail to provide a complete representation of
glucose oscillations. First, glycaemic variability is a
complex phenomenon that includes both intraday and
interday variability. Thus, glycaemic variability is the com-
posite of vertical and horizontal components. The second
reason why it is a complex phenomenon is that the glycae-
mic response is a combination of minor and major glucose
fluctuations. It is still difficult to know whether the delete-
rious effects of glycaemic variability, such as activation of
oxidative stress, are only triggered by major glucose swings
or by all glucose oscillations, including the minor ones. For
this reason, it is not surprising that several approaches have
been developed for quantifying glycaemic variations. From
a statistical point of view, the SD around the mean glucose
value appears as the ‘gold standard’ for quantifying glycae-
mic variability. By contrast, the MAGE index is probably
more appropriate for selecting the major glucose swings
that are calculated as the arithmetic mean of differences
between peaks and nadirs, provided that the differences are
greater than the SD around the mean values. Furthermore,
calculating the MAGE index requires CGM, which has
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the advantage of detecting all upward and downward
acute glucose fluctuations (157). Finally, the mean of daily
differences currently remains the sole index for estimating
interday glycaemic variability. This parameter is calculated
as the mean of absolute differences between glucose values
at the same time on two consecutive days.
Underlying mechanisms
It has been suggested that nitric oxide (NO), a potent
vasodilatator, may play a key role in hyperglycaemia-
induced oxidative stress and related effects on inflam-
mation, endothelial function and insulin sensitivity.
Hyperglycaemia may induce NO oxidation (164), thereby
leading to reduced NO concentrations, which then lead to
impairments in vasodilation. Indeed, alloxan diabetic rats
are observed to have reduced NO concentrations in blood
(165), and in human subjects, acute hyperglycaemia attenu-
ated endothelium-dependent vasodilatation (166). The fact
that such a decrease can be prevented by supplying various
antioxidants such as vitamin C, E and alpha-lipoic acid
(167–169) or L-ariginine, the precursor of NO (165,170),
suggests that increased NO oxidation, and the related NO,
reduces impact on the vascular epithelial cells. Indeed, res-
toration of NO availability results in the normalization of
endothelial function as well as insulin sensitivity (168,169).
Secondly, it has been hypothesized that acute hyperglycae-
mia may induce a depletion of vitamin C from cells because
vitamin C and glucose share a common transport system
and oxidative stress leads to use of intracellular vitamin
C (171). Thirdly, elevated glucose, elevated lipids and
hyperinsulinaemia occur simultaneously, in particular in
the postprandial state (141). As hypothesized by Evans
(167,172), chronic elevation of hyperglycaemia and FFA
cause oxidative stress along with the activation of stress-
sensitive signalling pathways, like nuclear factor kB
(NFkB), p38 MAPK and NH2-terminal Jun kinases/stress-
activated protein kinases pathways. This happens along
with the activation of the advanced glycosylation end-
products (AGE) receptor (RAGE), PKC and sorbitol stress
pathways. Activation of these pathways, in turn, worsens
both insulin action and secretion, leading to overt T2DM
and playing a key role in the late complications of T1DM
and T2DM. Glucose causes oxidative stress because of an
increased production of ROS, non-enzymatic glycation of
proteins and glucose auto-oxidation. Elevated FFA can
cause oxidative stress because of increased mitochondrial
uncoupling and ß-oxidation, the latter leading to an
increased production of ROS and to an activation of stress-
sensitive signalling pathways, which in turn impair insulin
secretion and action.
It is important to note the fact that in human endothelial
cells, in vitro elevation of extracellular D-glucose is not
sufficient to promote a deleterious effect on vasculature but
that a pro-inflammatory stimulus such as IL-1b is neces-
sary. These data support a synergistic action of hypergly-
caemia and inflammation and highlight the pivotal role of
a pro-inflammatory environment in diabetes as a critical
factor conditioning the early pro-atherosclerotic actions of
hyperglycaemia (173). The precise mechanisms through
which glucose variability may be worse than constant
glucose levels remains incompletely defined. Studies in cells
and animals have shown that in oscillatory pathways
involving PKC, NADPH (174), inducible NO synthase
(164) or inflammatory marker responses are more activated
as a result of intermittent glucose than by constant high
glucose levels (175,176).
Role of diet
Studies of GI and dietary GL provide further support that
postprandial hyperglycaemia increases the risk of CVD and
T2DM. Hu et al. (177) observed a stepwise relationship
between dietary GI and oxidative stress markers in healthy
adults. Furthermore, high-GI carbohydrates increase NFkB
activation and NFkB binding in mononuclear cells of
young, lean healthy subjects (146). Diets low in GL and
high in whole grains may have a protective effect against
systemic inflammation in diabetic patients, as reviewed
elsewhere (178). Consistent with this, epidemiological
studies show an inverse relationship between dietary fibre
and C-reactive protein (CRP) levels. Both the DASH diet
(naturally high in fibre, i.e., 30 g fibre d-1) and a fibre-
supplemented usual diet (30 g psyllium fibre d-1) decreased
CRP concentration, but this finding was only significant in
lean normotensive subjects in both intervention arms (179).
On the other hand, a high-carbohydrate, low-fat diet with
a relatively high dietary fibre and complex carbohydrate
content, within the context of a lifestyle intervention pro-
gramme, has been shown to reduce diabetes incidence in
the long-term by 50% (5–7).
The prominent role of type of carbohydrate is also illus-
trated in studies showing that dietary carbohydrate modi-
fication, i.e. an oat/wheat/potato diet, upregulated 62 genes
related to stress, cytokine-chemokine-mediated immunity
and the IL pathway compared with a rye–pasta diet (180).
As discussed above, these differences in inflammatory
response may be related to differences in the early insulin
response and the resultant late hypoglycaemia in the oat/
wheat/potato diet group.
A noteworthy development is the increasing interest in the
role of non-digestible carbohydrates in the manipulation of
gut microbiota, thereby affecting energy harvesting from the
gut, obesity, incretin levels, glucose intolerance and the
pro-inflammatory response. Animal studies have proposed
mechanisms bywhich amicrobiota-related signalmay link a
high-fat diet to the development of obesity and IR by
promoting a low-grade inflammatory state by increasing
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gut and systemic bacterial lipopolysaccharides derived
from gram-negative bacteria (partly mediated through an
increased leakage from the gut) (181). Currently, there is an
urgent need for confirmation of these effects in humans
using targeted intervention studies. Thus, appropriate
dietarymeasures may have the potential to reduce postpran-
dial glucose and postprandial glucose variability.
Conclusion
The progressive relationship between plasma glucose and
CVD, and the finding that there appears to be no glycaemic
threshold for the reduction of either micro- or macrovas-
cular complications (182), indicates that early treatment/
prevention of hyperglycaemia is important. Furthermore,
because there is no clear threshold for the adverse health
effects, prevention of hyperglycaemia is of utmost impor-
tance in diabetes as well as in healthy volunteers and high-
risk subjects. The goal should be to achieve a glycaemic
status as close to normal as is safely possible in all three
measures of glycaemic control: fasting glucose, HbA1c and
postprandial glucose. Finally, large lifestyle intervention
trials have shown that appropriate dietary measures are of
benefit in reducing postprandial glucose and postprandial
glucose variability.
Prevention of diabetes and IR3
Introduction
T2DM is mainly due to an association between a defect
in insulin secretion and IR. It leads to alteration of post-
prandial glycaemia with both higher glucose levels and
sustained hyperglycaemia. Better glycaemic control, as
assessed by glycated haemoglobin (HbA1c), should be
obtained by control of both fasting plasma glucose values
(183) and post-meal glycaemia as recently highlighted
(184). Actual recommendations for diabetes care are that
postprandial glycaemia should not exceed 140 mg dL-1,
2 h after a meal. Thus, strategies targeting postprandial
glycaemia are being developed, including both dietary
approaches to reduce dietary GL and pharmacological
approaches involving the use of specific drugs (a glucosi-
dase inhibitors, glinides, GLP-1 derivatives, rapid-acting
insulin) (182). However, whether or not reduction of post-
prandial glycaemia will reduce the risk of diabetes in
healthy or at-risk subjects remains controversial.
In this section, the role of postprandial glycaemia in the
prevention of diabetes in healthy or at-risk subjects with an
IGT will be addressed. Years that precede the development
of T2DM are characterized by a progressive decline in both
insulin action and defects in the early phase of the insulin
secretion, with losses of postprandial glucose regulation
occurring before overt diabetes (185). To prevent diabetes,
modulation of postprandial glycaemia should interfere
either with insulin sensitivity and/or with insulin secretion.
Such interactions can be speculated in accordance with the
concept of glucotoxicity and glucolipotoxicity and their
potential action on both insulin secretion and insulin sen-
sitivity. We will review epidemiological data and interven-
tion studies. For shorter-term interventions, attention will
be paid to actions on either insulin sensitivity or secretion.
Data on the link between postprandial glycaemia and
risk of diabetes could only be obtained in long-term
studies. With respect to the latter studies, we will only
report interventions specifically targeting postprandial
glucose response, which are mainly drug interventions as
lifestyle interventions are not thought to have a specific
effect on postprandial glucose. Finally, potential underlying
mechanisms will be considered.
Observational data in cohorts
The link between diet and the risk of diabetes has been
studied in numerous prospective studies in large cohorts.
As carbohydrate is the main dietary component affecting
insulin secretion and postprandial glycaemia, attention has
been focused on this macronutrient. Both the amount and
the type of carbohydrate have an effect on postprandial
glycaemia and insulin secretion, and GI and GL are indi-
cators of postprandial glucose response. Decreased risk of
diabetes has been shown to be associated with an LGI diet.
Willett et al. (10) have used data from a large prospective
epidemiological study of women (Nurses’ Health Study) as
well as data from a large prospective epidemiological study
of men (Health Professional’s Follow-Up Study) to verify
the hypothesis that high dietary GI and/or GL increases the
risk of T2DM. They showed that women in the highest
quintile of GL had a 40% greater risk of T2DM as com-
pared with women in the lowest quintile. Addtionally, for
men in the extreme upper categories of GL and lower
categories of cereal fibre intake, the relative risk (RR) of
diabetes was RR = 2.17 (high glycaemic load [>188] and
low cereal fiber intake [<3.2]). In the Nurses’ Health Study,
Liu et al. (186) observed that fasting triacylglycerol con-
centrations were nearly twofold higher among women in
the highest GL quintile than among those in the lowest
quintile. Barclay et al. (187) used meta-analysis techniques
to evaluate the association between GI and/or GL and the
occurrence of several chronic diseases. For this purpose,
these authors selected (among 274 potentially relevant
references) 37 original prospective observational cohort
studies from which 8 were devoted to the risk of diabetes.
Of these 8 studies, 6 were in favour of an association and
3The main authors of this section are Martine Laville, Sophie Vinoy, Sylvie
Normand and Jens Juul Holst, Signe Sørensen Torekov for the incretin
parts.
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2 were not. Based on comparisons between subjects ingest-
ing diets with high or LGI and/or GL, the meta-analysis
showed that a high GI or GL independently increased the
risk of T2DM (GI RR = 1.4, GL RR = 1.27).
Taken together, these observational data suggest that
replacing high-GI with LGI carbohydrates reduces the risk
of metabolic disturbances and T2DM. Nevertheless, incon-
clusive results were also found in some studies. Method-
ological issues might explain the failure to show the
association between LGI and/or GL and the development
of T2DM. For example, in the large prospective cohort of
35,988 older Iowa women studied by Meyer et al. (188),
the GI or GL was not significantly related to the risk of
T2DM. This could have been due in part to the use of a
single measure of dietary intake and/or the fact that the
presence of T2DM was based on self-report without con-
firmatory information.
Decreased diabetes risk has also been shown to be asso-
ciated with whole-grain (189) and green leafy vegetable
intake (190) and even nut consumption (191). From these
studies, it is not possible to know if these diets influence
postprandial glycaemia, but we have several arguments to
think so. The RR of T2DM for the highest as compared
with the lowest quintile of whole-grain intake was 0.63
in the Nurses’ Health Study I and 0.68 in the Nurses’
Health Study II. Vegetables, unrefined whole grain and
bran products are complex substances that contain both
soluble and insoluble fibre. Soluble viscous fibres reduce
postprandial glucose responses and cereral insoluble fibres
have been shown to improve insulin sensitivity in over-
weight and obese subjects using a euglycaemic hyperin-
sulinic clamp over 3 d (192). Moreover, after 1 d of
consumption, the postprandial glycaemic response was
significantly decreased with no change in peak glucose
but with a decrease in AUC. It was associated with an
increase in early insulin and GIP secretion (193). Thus,
fibre consumption seems to be associated with a decrease
in postprandial glucose AUC. This effect should be at
least partly responsible for the reduced risk of diabetes
found in whole-grain consumers. Finally, in the Nurses’
Health Study, nut consumption has been shown to be
associated with a decreased risk of T2DM (RR 0.78 for
more consumption than five times per week compared
with never) (191), and nuts have been shown to decrease
the postprandial glucose response in a dose-dependent
manner (decreased AUC and peak) (194). Thus, most
observational studies show that diets decreasing post-
prandial glycaemia are associated with a lower risk of
diabetes.
Long-term intervention studies
Acarbose is an a-glucosidase inhibitor that reduces post-
prandial glycaemia by decreasing glucose absorption. The
STOP-NIDDM study randomly allocated 714 participants
with IGT to 100 mg of acarbose and 715 participants to
placebo. The risk of progression to diabetes over 3.3 years
was reduced by 25%with acarbose. Furthermore, acarbose
increased the probability that IGT would revert to normal
glucose tolerance over time (195). On the contrary, in the
Early Diabetes Prevention Program, 219 subjects with early
diabetes (HbA1C = 6.3%) were randomly assigned to
100 mg of acarbose or placebo with a follow-up of 5 years.
Despite a decrease in postprandial glycaemia (post-peak
and AUC) under acarbose, there was no difference in the
cumulative incidence of fasting hyperglycaemia. However,
a post hoc analysis showed that in subjects with initial
fasting glycaemia lower than 126 mg dL-1, acarbose
reduced the rate of development of fasting hyperglycaemia.
This suggests that the lack of observed effect during the
study was due to the inclusion of subjects with a too far
advanced stage of glucose metabolism abnormalities. A
meta-analysis of the a glucosidase inhibitor intervention
studies included five trials with IGT or at-risk subjects
and confirms the reduced risk of diabetes by, on average,
20% (196).
The NAVIGATOR study, a double-blind, randomized
clinical trial, assigned 9,306 participants with IGT or car-
diovascular risk factors to receive nateglinide (up to 60 mg
three times daily) or placebo, in a 2-by-2 factorial design
with nateglinide or placebo, in addition to participation in
a lifestyle modification programme (197). Nateglinide is a
short-acting insulin secretagogue. It reduces postprandial
glucose by enhancing insulin secretion. However, this treat-
ment was unable to reduce the incidence of diabetes. The
difference between this study and the acarbose trials may
be due to the difference in action of the two drugs, i.e. the
induced insulin secretion by nateglinide compared with the
reduced blood glucose response through decreasing glucose
absorption with acarbose.
The human GLP-1 analogues are now currently used for
the treatment of T2DM. These analogues decrease HbA1c
by improving insulin secretion through restoring the first
phase of insulin secretion, acting mostly on postprandial
glycaemia. The GLP-1 analogue liraglutide has been given
to a large group of overweight/obese participants (4% with
T2DM, 33% with an impaired glucose metabolism,
63% healthy volunteers) for 20 weeks (63). During therapy
(which led to significant and durable weight losses) glucose
tolerance was normalized in 90% of the subjects. Insulin
sensitivity assessed by homeostatic model assessment
(HOMA) index was unchanged, whereas b cell function
was improved (HOMA b). Longer-term studies are
required, but these initial results appear very promising.
Differences in the profile of insulin secretion between
glinides and GLP-1 agonists could possibly explain the
differences between the results of the latter study and the
NAVIGATOR study. Thus, long-term interventions with
942 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity13, 923–984, October 2012
drugs targeting postprandial glycaemia could be efficient in
reducing the risk of diabetes, but the results are dependent
upon both the mechanism by which the postprandial gly-
caemia is decreased and the glucometabolic status of the
subjects, intervention being less efficient in subjects with a
too far advanced stage of abnormalities in glucose metabo-
lism (196).
Short-term intervention studies
For short-term intervention studies, it is important to
examine intermediate risk markers for T2DM such as the
postprandial glycaemic response in relation to insulin
sensitivity or insulin secretion. Maintenance of a normal
plasma glucose concentration requires precise balance
between glucose utilization, its endogenous production
mainly by the liver (glycogenolysis and neoglucogenesis)
and its exogenous absorption at the intestinal level. The
rise in postprandial glycaemia will depend on the quality
of the ingested carbohydrate, on its interaction with other
compounds, as well as on the ability of the participant to
clear the glucose by insulin-induced glucose utilization.
The type of carbohydrate and its digestibility, the quantity
of carbohydrates as compared with other macronutrients
such as lipids, proteins and fibres are all confounding
parameters that can dramatically modify the post-meal
metabolic response. Thus, we aim to review the influence
of the type of carbohydrate on the postprandial glucose
response and the metabolic consequences on insulin sensi-
tivity and secretion. Unfortunately, in several intervention
studies, the information on the characteristics of the post-
prandial glucose response are not detailed and sometimes
not even controlled, and the diet has mostly been only
characterized by GI.
Influence of the type of carbohydrate
Intervention studies examining the influence of carbohy-
drate on IR and diabetes have compared different types of
carbohydrates, mainly SUC vs. fructose vs. starch. These
studies are often short-term, but the time course of glycae-
mia, insulinaemia and TGs are often described. After inges-
tion of fructose, postprandial glucose is reduced compared
with after SUC. Nevertheless, fructose may stimulate liver
lipogenesis that may increase triacylglycerol concentra-
tions. These effects are dose dependent and low intake of
fructose (less than 50 g d-1) could be beneficial by decreas-
ing Hba1c and glycaemic reponse, whereas a high amount
(more than 90 g d-1) may be deleterious with decreased
insulin sensitivity, an increased liver fat content and
increased TGs (51,52,198,199).
Several acute intervention studies in healthy participants
show that the preservation of starch in its original state,
which is low gelatinized (i.e. slowly digested), induces a
lower glycaemic response and a lower insulin demand
during the post-meal period compared with several pro-
cessed starchy foods in which starch is highly gelatinized
(rapidly digested) (22,200–203). The mechanism by which
less gelatinized starch leads to a lower glycaemic and
insulin response has been identified using isotope-labelling
methods. The authors demonstrated that the consumption
of a cereal product with a high content of slowly available
glucose induced a lower appearance rate of exogenous
glucose in the bloodstream during the postprandial
period (204).
Intervention studies where postprandial excursion of
glucose is followed are mainly based on GI manipulations.
The introduction of LGI foods into a daily diet is able to
decrease the global hyperglycaemia level across the whole
day in healthy subjects, with lower hyperglycaemic peaks
after meals and lower glycaemia during post-absorptive
phases, which may be most pronounced during the night
(205,206). However, discrepancies are observed in these
results and may begin with the definition of low- vs. high-
glycaemic diets. Foods that do not contain carbohydrates
or that do no contain enough carbohydrates to raise blood
glucose should not be included in the estimation of the GI
value of diets (207), and a large range of values is obtained
for the difference in GI between the high- vs. the LGI
diets. Moreover, despite a good selection of food products
belonging to the low- and high-GI diets, some studies failed
to show differences in postprandial glucose kinetics (56).
This was also the case for the study by Black et al. (208),
who showed no differences in glycaemic profiles obtained
using CGM during 25% vs. 10% SUC diets in healthy
participants. Finally, numerous studies investigating differ-
ent GI diets did not report the effect of their intervention on
postprandial glycaemia.
Short-term intervention studies
Tables 3–5 report the 21 different intervention studies, 11
of which were able to show an effect either on insulin
sensitivity or on insulin secretion, whereas 10 were not.
Only 9 studies reported postprandial glycaemic param-
eters. Four of these studies showed no differences in post-
prandial glycaemia between the two intervention groups.
We therefore decided to comment only on the five papers in
which postprandial glycaemia was mentioned and was sig-
nificantly different between groups.
In overweight participants, a similar decrease in post-
prandial glucose and postprandial insulin responses was
found after 4 and 5 weeks of consuming an LGI diet
compared with a relatively high-GI diet, which was asso-
ciated with a slight weight or fat mass reduction (39,40),
respectively. Brynes et al. also showed an improvement
in insulin sensitivity (as estimated by HOMA) after
repeated lower glucose excursions, whereas Bouché et al.
showed no difference. The difference in the effect on
insulin sensitivity may be related to the magnitude of the
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blood glucose response difference between both GI diets.
During the experimental days, in the study by Bouché and
collegues, mean blood glucose peaks after breakfast were
7.7 mmol L-1 and 6.6 mmol L-1 for high- vs. LGI diets after
5 weeks of intervention, while in the study by Brynes and
colleagues, mean blood glucose peaks after breakfast
were 8.9 mmol L-1 and around 7.5 mmol L-1 after 4 weeks
of intervention. Moreover, in the study by Nazare and
co-workers, the authors could not find any improvement in
insulin sensitivity after 5 weeks of an LGI diet compared
with a high-GI diet in overweight subjects (204). One of the
explanations may be that the magnitude of difference in
glucose responses was too low (less than 1 mmol L-1 dif-
ference at the mean blood glucose peaks after breakfast
between both diets) and that there were no significant
differences in insulin responses between both test break-
fasts and lunch during the experimental days. Another
explanation would be that the Nazare sample was younger
and had lower basal glycaemia, insulinaemia and total
cholesterol compared with the Brynes and Bouché studies.
In another study on seven overweight women with IGT, the
authors evaluated modest dietary changes by modulating
the GI characteristics and the dietary fibre content of bread,
eaten during 3 weeks as part of their usual diet (209). The
LGI/high-fibre bread diet led to a reduced insulinaemic
response of 35% during the first hour after euglycaemic-
hyperinsulinaemic clamp but had no impact on glucose
response (209).
Additonally, in the study of Bouché and colleagues the
authors showed that fasting total cholesterol and Apo
Lipoprotein B decreased after an LGI diet period of 5 weeks
(39). The effect of a reduced postprandial glucose response
on fat metabolism in obese non-diabetic subjects was
found elsewhere. During the same intervention period
(as in Bouché et al.), De Rougemont et al. showed a
10% decrease in total cholesterol, a 9% decrease in LDL
cholesterol and a 10% decrease in the ratio of LDL : high-
density lipoprotein (HDL)-chlolesterol, after an LGI diet
compared with after a high-GI diet (59). Harbis et al. dem-
onstrated that a meal rich in slowly digestible carbohy-
drates induced low glycaemic and insulinaemic responses,
and reduced the postprandial accumulation of both hepati-
cally and intestinally derived triacylglycerol-rich lipopro-
teins in obese subjects with IR (210).
Livesey et al. (51,52) performed a systematic review
of experimental data reported in intervention studies
on the association between GI and markers of metabolic
disorders through the use of meta-analysis and meta-
regression models. Participants were either normal weight
(16 studies), overweight (18 studies), obese (10 studies)
or unclassified by weight (1 study). Study participants
were either healthy, i.e. no evident diagnosis of disease
(13 studies), or had IGT (2 studies) or had T1DM (7
studies), or T2DM (17 studies) or were at risk of primaryTa
bl
e
4
S
tu
d
ie
s
sh
ow
in
g
an
ef
fe
ct
on
in
su
lin
se
cr
et
io
n
S
tu
d
ie
s
D
es
ig
n
d
ur
at
io
n
S
ub
je
ct
s
A
g
e
B
M
I
In
te
rv
en
tio
n
P
os
tp
ra
nd
ia
lg
lu
co
se
p
ro
fil
e
P
os
tp
ra
nd
ia
li
ns
ul
in
p
ro
fil
e
E
ffe
ct
on
b
od
y
w
ei
g
ht
E
ffe
ct
on
fa
st
in
g
g
lu
co
se
E
ffe
ct
on
fa
st
in
g
in
su
lin
ae
m
ia
E
ffe
ct
on
in
su
lin
se
ns
iti
vi
ty
(m
et
ho
d
us
ed
)
E
ffe
ct
on
in
su
lin
se
cr
et
io
n
(m
et
ho
d
us
ed
)
E
ffe
ct
on
ho
rm
on
es
S
tu
d
ie
s
w
ith
d
at
a
on
p
os
tp
ra
nd
ia
lk
in
et
ic
s
O
st
m
an
et
al
.
20
06
(2
09
)
R
,
P
3
w
ee
ks
w
ith
3-
w
ee
k
w
as
ho
ut
7
w
ee
ks
IG
T
A
g
e
27
–4
1
B
M
I=
28
H
G
I/L
G
I+
in
so
lu
b
le
D
F
D
ec
re
as
e
p
ea
k
an
d
A
U
C
w
ith
LG
I
fo
r
g
lu
co
se
an
d
in
su
lin
p
ro
fil
es
N
o
N
ot
re
p
or
te
d
N
o
ch
an
g
e
(I
V
G
TT
+
cl
am
p
)
D
ec
re
as
e
in
su
lin
se
cr
et
io
n
(I
V
G
TT
)
S
tu
d
ie
s
w
ith
ou
t
d
at
a
on
p
os
tp
ra
nd
ia
lk
in
et
ic
s
W
ol
ev
er
an
d
M
eh
lin
g
20
02
(2
07
)
R
,
P
(4
m
on
th
s)
34
ob
-I
G
T/
7o
b
/8
he
al
th
y
A
g
e
56
B
M
I=
31
H
G
I/L
G
I/l
ow
ca
rb
oh
yd
ra
te
N
ot
re
p
or
te
d
D
ec
re
as
e
N
o
ef
fe
ct
N
o
ef
fe
ct
(b
y
FS
IG
TT
)
In
cr
ea
se
w
ith
LG
I
(b
y
FS
IG
TT
)
Ju
nt
un
en
et
al
.
20
03
(4
36
)
R
,
C
O
8
w
ee
ks
+
8-
w
ee
k
w
as
ho
ut
20
W
p
os
t-
m
en
op
au
sa
l
A
g
e
59
B
M
I=
28
W
he
at
b
re
ad
/r
ye
b
re
ad
(h
ig
h
fib
re
s)
N
ot
re
p
or
te
d
N
o
N
o
N
o
ef
fe
ct
(F
S
IG
TT
)
In
cr
ea
se
w
ith
LG
I
(F
S
IG
TT
)
A
U
C
,
ar
ea
un
d
er
th
e
cu
rv
e;
B
M
I,
b
od
y
m
as
s
in
d
ex
;
C
O
,
cr
os
so
ve
r;
D
F,
d
ie
ta
ry
fib
re
;
FS
IG
TT
,
fre
q
ue
nt
ly
sa
m
p
le
d
in
tr
av
en
ou
s
g
lu
co
se
to
le
ra
nc
e
te
st
;
H
G
I,
hi
g
h
g
ly
ca
em
ic
in
d
ex
;
IG
T,
im
p
ai
re
d
g
lu
co
se
to
le
ra
nc
e;
IV
G
TT
,
in
tr
av
en
ou
s
g
lu
co
se
to
le
ra
nc
e
te
st
;
LG
I,
lo
w
g
ly
ca
em
ic
in
d
ex
;
M
,
m
en
;
ob
,
ob
es
e;
P,
p
ar
al
le
l;
R
,
ra
nd
om
iz
ed
;
W
,
w
om
en
.
obesity reviews Postprandial glycaemia and health E. E. Blaak et al. 945
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity 13, 923–984, October 2012
Ta
bl
e
5
S
tu
d
ie
s
sh
ow
in
g
no
ef
fe
ct
on
in
su
lin
se
cr
et
io
n
S
tu
d
ie
s
D
es
ig
n
d
ur
at
io
n
S
ub
je
ct
s
A
g
e
B
M
I
In
te
rv
en
tio
n
P
os
tp
ra
nd
ia
lg
lu
co
se
p
ro
fil
e
an
d
in
su
lin
p
ro
fil
e
E
ffe
ct
on
b
od
y
w
ei
g
ht
E
ffe
ct
on
fa
st
in
g
g
lu
co
se
an
d
on
fa
st
in
g
in
su
lin
ae
m
ia
E
ffe
ct
on
in
su
lin
se
ns
iti
vi
ty
(m
et
ho
d
us
ed
)
E
ffe
ct
on
in
su
lin
se
cr
et
io
n
(m
et
ho
d
us
ed
)
E
ffe
ct
on
ho
rm
on
es
S
tu
d
ie
s
w
ith
d
at
a
on
p
os
tp
ra
nd
ia
lk
in
et
ic
s
D
e
R
ou
g
em
on
t
et
al
.
20
07
(5
9)
R
,
P
(5
w
ee
ks
)
38
M
/1
9
W
A
g
e
40
B
M
I=
27
H
G
I
(6
6)
/L
G
I
(4
6)
D
ec
re
as
e
in
LG
I
N
o
ef
fe
ct
N
o
(H
O
M
A
)
N
az
ar
e
20
10
et
al
.
(2
04
)
R
,
P
(5
w
ee
ks
)
38
M
/1
9
W
A
g
e
40
B
M
I=
27
H
G
I
(6
6)
/L
G
I
(4
6)
D
ec
re
as
e
p
ea
k
an
d
A
U
C
of
g
lu
co
se
re
sp
on
se
N
o
ch
an
g
e
in
in
su
lin
N
o
(t
es
t
m
ea
l)
N
o
(T
es
t
m
ea
l)
B
ou
ch
e
et
al
.
20
02
(3
9)
R
,
C
O
5
w
ee
ks
w
ith
5-
w
ee
k
w
as
ho
ut
11
ov
er
w
ei
g
ht
A
g
e
46
B
M
I=
28
H
G
I
(7
5)
/L
G
I
(4
0)
D
ec
re
as
e
p
ea
k
an
d
A
U
C
of
g
ly
ca
em
ic
re
sp
on
se
,
d
ec
re
as
e
p
ea
k
of
in
su
lin
re
sp
on
se
N
o
ch
an
g
e
N
o
ef
fe
ct
N
o
m
od
ifi
ca
tio
n
(H
O
M
A
)
N
o
m
od
ifi
ca
tio
n
(H
O
M
A
B
)
A
st
on
et
al
.
20
08
(5
6)
R
,
C
O
12
-w
ee
k
in
te
rv
en
tio
n
w
ith
ou
t
w
as
ho
ut
19
W
A
g
e
52
B
M
I=
33
H
G
I
(7
5)
/L
G
I
(5
0)
;
ho
w
ev
er
,
th
e
re
al
G
I
d
iff
er
en
ce
is
8
p
oi
nt
s
N
o
ch
an
g
e
N
o
ch
an
g
e
N
ot
d
es
cr
ib
ed
N
ot
d
es
cr
ib
ed
B
la
ck
et
al
.
20
06
(2
08
)
R
,
C
O
6
w
ee
ks
w
ith
4-
w
ee
k
w
as
ho
ut
13
he
al
th
y
A
g
e
33
B
M
I=
26
10
vs
.
25
%
su
cr
os
e
N
o
d
iff
er
en
ce
G
C
M
S
N
o
N
o
(c
la
m
p
)
S
tu
d
ie
s
w
ith
ou
t
d
at
a
on
p
os
tp
ra
nd
ia
lk
in
et
ic
s
S
lo
th
et
al
.
20
04
(4
1)
R
,
P
10
w
k
45
W
A
g
e
30
B
M
I=
28
H
G
I/L
G
I
In
vi
tro
G
I:
10
3/
79
(b
re
ad
re
fe
re
nc
e)
an
d
no
d
iff
er
en
ce
in
re
si
st
an
t
st
ar
ch
co
nt
en
t
N
ot
re
p
or
te
d
D
ec
re
as
e
in
b
ot
h
g
ro
up
s
B
as
al
b
lo
od
g
lu
co
se
in
cr
ea
se
in
LG
I.
N
o
ch
an
g
e
on
in
su
lin
.
N
o
d
iff
er
en
ce
(H
O
M
A
)
N
o
d
iff
er
en
ce
(H
O
M
A
B
)
P
hi
lip
p
ou
et
al
.
20
09
(4
37
)
R
,
P
4
m
on
th
s
41
su
b
je
ct
s
A
g
e
18
–6
5
B
M
I=
32
H
G
I/L
G
I
N
ot
re
p
or
te
d
N
o
N
o
N
o
d
iff
er
en
ce
(H
O
M
A
)
N
o
d
iff
er
en
ce
(H
O
M
A
B
)
Li
et
al
.
20
03
(4
38
)
R
,
C
O
4
w
ee
ks
w
ith
1-
m
on
th
w
as
ho
ut
10
he
al
th
y
W
A
g
e
20
B
M
I=
19
S
ta
nd
ar
d
d
ie
t/B
ar
le
y
d
ie
t
(+
d
iff
er
en
ce
in
fib
re
s)
N
ot
re
p
or
te
d
N
o
N
o
N
o
d
iff
er
en
ce
(O
G
TT
)
N
o
d
iff
er
en
ce
(O
G
TT
)
A
nd
er
ss
on
et
al
.
20
07
(4
39
)
R
,
C
O
6
w
ee
ks
w
ith
6-
to
8-
w
ee
k
w
ha
sh
ou
t
30
su
b
je
ct
s
(8
M
)
A
g
e
59
B
M
I=
28
W
ho
le
g
ra
in
/re
fin
ed
g
ra
in
s
N
ot
re
p
or
te
d
In
cr
ea
se
on
w
ho
le
g
ra
in
N
o
ef
fe
ct
N
o
d
iff
er
en
ce
(c
la
m
p
)
D
av
y
et
al
.
20
02
(4
40
)
R
,
P
12
w
ee
ks
36
M
A
g
e
60
B
M
I=
29
O
at
/w
he
at
fo
od
s
at
b
re
ak
fa
st
an
d
sn
ac
ks
N
ot
re
p
or
te
d
In
cr
ea
se
of
0.
8
kg
in
b
ot
h
g
ro
up
s
N
o
ef
fe
ct
N
o
d
iff
er
en
ce
(I
V
G
TT
)
A
U
C
,
ar
ea
un
d
er
th
e
cu
rv
e;
B
M
I,
b
od
y
m
as
s
in
d
ex
;
C
O
,
cr
os
so
ve
r;
G
C
/M
S
,
g
as
ch
ro
m
at
og
ra
p
hy
an
d
m
as
s
sp
ec
tro
m
et
ry
;
H
G
I,
hi
g
h
g
ly
ca
em
ic
in
d
ex
;
H
O
M
A
,
ho
m
eo
st
at
ic
m
od
el
as
se
ss
m
en
t;
IV
G
TT
,
in
tr
av
en
ou
s
g
lu
co
se
to
le
ra
nc
e
te
st
;
LG
I,
lo
w
g
ly
ca
em
ic
in
d
ex
;
M
,
m
en
;
O
G
TT
,
or
al
g
lu
co
se
to
le
ra
nc
e
te
st
;
P,
p
ar
al
le
l;
R
,
ra
nd
om
iz
ed
;
W
,
w
om
en
.
946 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity13, 923–984, October 2012
CHD (4 studies) or secondary CHD (1 study) or had
hyperlipidaemia (1 study). The analysis shows that diets
with an LGI reduced both fasting blood glucose and gly-
cated protein levels. These effects were greater in partici-
pants with poor fasting blood glucose control but were also
observed for fasting capillary blood glucose levels slightly
above 5 mM. Twelve studies reported an increase in insulin
sensitivity in non-diabetic subjects on an LGI diet. Hence,
diets with an LGI have a beneficial impact on some bio-
logical parameters such as fasting blood glucose, glycated
protein control and insulin sensitivity in healthy subjects.
Unfortunately, insufficient data on postprandial glucose
profiles were available.
Finally, short-term intervention studies give no clear-cut
results. The number of studies is too low, the studies are too
heterogenous for the type of intervention and measure-
ments of postprandial parameters are too scarce to be able
to drive conclusions. More studies devoted to this question
are required. However, the last meta-analysis showed a
positive impact in the reduction of postprandial blood
glucose on the prevention of diabetes (51,52). Furthermore,
it seems that in order to evaluate the impact of postprandial
hyperglycaemia on glucose and lipid metabolism, it is
necessary to sufficiently manipulate the meals or diets to
obtain a difference.
Experimental arguments – mechanisms
The mechanisms by which modulation of postprandial gly-
caemia can interfere with insulin sensitivity and secretion
and thus the risk of diabetes involve the concept of glucoli-
potoxicity. This concept has been largely illustrated on
insulin secretion with experiment on pancreatic islet but has
also been demonstrated in humans, particularly in T2DM.
The pathophysiology of IR has been more related to
lipotoxicity than to glucotoxicity. IR is often characterized
by systemic lipid overflow, leading to lipid accumulation in
non-adipose tissues (ectopic fat accumulation), which is a
strong risk marker for IR. Lipid uptake by muscle is largely
dependent on the circulating FFA and TG concentrations.
Glycaemia, insulinaemia, and TG and FFA levels are closely
linked. Manipulation of postprandial glucose could be
associated with either an increased insulin secretion (if
decrease of glycaemia is induced by insulin secretion) or a
decreased insulin secretion, as is usually the case with
studies of LGI. An increase in insulin secretion in the short-
term is associated with a decrease in TG and FFA concen-
trations and lipid oxidation that should be favourable for
insulin sensitivity, as in the short-term this may reduce lipid
overflow and reduce ectopic fat accumulation. However,
subjects prone to T2DM have an increase in body weight
and (dysfunctional) fat mass that leads to increased level of
TGs and fatty acids. Recent studies have shown that an
increased fat mass and the accompanying hyperinsuli-
naemia are inversely related to expression of lipoytic
enzymes in adipose tissue (adipose triglyceride lipase,
hormone sensitive lipase, etc.) and to whole body rate of
appearance expressed per unit fat mass. Thus, there is
mixed evidence for the notion that the obese insulin-
resistant or diabetic state is associated with raised post-
prandial, diurnal or nocturnal FFA concentrations and
more emphasis may be placed on raised TGs as a source of
lipid overflow. Nevertheless, in diabetic subjects an increase
in postprandial glycaemia will be associated with higher
TGs and/or FFA levels as compared with normal subjects.
Finally, the effect of incretins on insulin secretion, which is
now highlighted in the context of treatment of diabetes and
bariatric surgery, could be a powerful tool for decreasing
postprandial glucose and for preventing diabetes. Long-
term studies using incretin or dietary manipulations aimed
at modulating their secretion are required.
Glucolipotoxicity of glucose on pancreas
To better understand the effect of hyperglycaemia on meta-
bolic disease genesis, we can consider the potential toxicity
of glucose, especially on the pancreas. It has been well
documented that supraphysiological glucose concentra-
tions may damage a large number of organs in non-
controlled diabetes. However, chronic hyperglycaemia may
promote the development of the early diabetic state by
affecting the secretion capacity of pancreatic cells, which
may subsequently increase blood glucose concentrations
further. This vicious circle finally leads to the total failure of
b-cells to secrete insulin (211). Moreover, excess of lipids
added their deleterious effect to hyperglycaemia, leading to
the concept of glucolipotoxicity. This could perhaps under-
lie the decrease in b-cell mass documented in patients with
IGT, the earliest manifest stage of T2DM (212). These two
recent reviews (211,212) synthesized the role of hypergly-
caemia in the glucotoxicity. Long-term hyperglycaemia is
able to induce the generation of ROS leading to chronic
oxidative stress because the islets express very low levels of
antioxidant enzymes and activity. However, these findings
for chronic hyperglycaemia have not been demonstrated
for postprandial glycaemic excursions.
Lipids and muscle IR
An increasing number of studies have linked lipid accumu-
lation in skeletal muscles to reduced insulin sensitivity in
T2DM patients. In addition, intracellular lipid metabolites,
such as fatty acyl-CoA, diacylglycerol or ceramide, have
been shown to inhibit insulin action via the activation of
serine/threonine kinases and serine phosphorylation of
insulin receptor substrate-1. There are a lot of experimental
pieces of evidence showing a link between FFA level and IR.
Lipid infusions, combined with heparin to activate lipopro-
tein lipase, raised plasma concentrations of fatty acids,
promoted the accumulation of muscle lipids and impaired
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oral glucose tolerance and insulin-stimulated glucose
disposal in healthy individuals (213). In addition, there is
growing evidence that besides lipid overflow and an
increased supply of fatty acids, mitochondrial dysfunction
in skeletal muscles, and subsequently an impaired ability to
oxidize fatty acids, also plays an important role in the
development of IR. Bonnard et al. (214) have shown that
both hyperglycaemia and hyperlipidaemia are involved in
oxidative stress and mitochondrial alterations.
Liver metabolism: impact of insulin and glucose
The liver plays a major role in the regulation of glucose,
lipid and energy metabolism. Acute elevations of circulat-
ing glucose concentrations decrease hepatic glucose output
by acting on gluconeogenesis at the level of the expression
of the PEPCK gene. The inhibitory effect of glucose on
gluconeogenesis is affected during prolonged hyperglycae-
mia. However, the underlying mechanisms of this phenom-
enon have not yet been elucidated.
The brain has a substantial impact on the regulation of
hepatic glucose metabolism. Moderate increases in extra-
cellular glucose concentrations within a specific region of
the hypothalamus markedly lower blood glucose through
the inhibition of hepatic glucose production. Moreover,
central inhibition of fat oxidation selectively activates spe-
cific neurons within the solitary tract nucleus and the vagal
dorsal motor nucleus, leading to decreased levels of gluco-
neogenic enzymes and thus reduced hepatic glucose pro-
duction. Hence, it has been shown that central glucose and
lipid mechanisms communicate with the liver via the vagal
nerve (215).
Under conditions of increasing glucose and insulin con-
centrations, lipid metabolism is affected by activating sterol
response element-binding protein 1c (SREBP-1c) and car-
bohydrate response element-binding protein. Both are
known to activate lipogenic enzymes in the liver (216).
Recently, a long-term (20 weeks) study in mice showed that
a high concentration of blood glucose through a high-GI
diet induced the expression of enzymes involved in the
regulation of de novo lipogenesis such as ACC and fatty-
acid synthase, as well as stearoyl-CoA desaturase-1. In
agreement with these findings, SREBP-1c was significantly
increased (76). Furthermore, a network of transcription
factors, repressors and activators act as sensors of hor-
monal and nutritional status (i.e. high glucose or insulin
levels) in order to coordinate enzyme activities and meta-
bolic pathways in the liver via Liver X receptors, which are
recognized as important regulators of cholesterol metabo-
lism, lipid and glucose homeostasis (216)).
Role of incretins
T2DM is characterized by a severely reduced or absent
incretin effect (217) (see also the section on weight man-
agement in this article), and this undoubtedly contributes
to the inappropriate insulin secretion that characterizes the
disease. It is now clear that the incretin defect is due to an
almost complete loss of the insulinotropic effect of GIP
(218,219), whereas the secretion of GIP is normal or
near normal (220). Regarding GLP-1, a significant and
sometimes substantial reduction in meal-induced GLP-1
secretion is found (220,221). In contrast to GIP, the insuli-
notropic effect of GLP-1 is retained in patients with T2DM
(218), and it is possible with infusions of GLP-1 to com-
pletely normalize glucose-induced insulin secretion in these
patients (219,222). However, from dose-response studies it
appears that the potency of GLP-1 with respect to enhanc-
ing glucose-induced insulin secretion is greatly reduced (to
approximately 20%) in the patients compared with healthy
controls (222). Thus, both defects in the secretion and
actions of the incretin hormones are responsible for the
reduced incretin effect and hence the inadequate insulin
secretion seen in these patients. The question then arises
whether these defects are primary or secondary in relation
to diabetes, but the evidence to date suggests that the
abnormalities are secondary to the development of diabetes
and/or IR (223–226).
In contrast to GIP, with pharmacological amounts of
GLP-1, it is possible to restore beta cell responsiveness to
glucose in T2DM patients, and this is currently being
exploited in the new therapeutic agents developed on the
basis of GLP-1 (exenatide [92,93,95] and liraglutide
[98–100,102,227]).
A dramatic example of the power of GLP-1 to regulate
postprandial glycaemia is provided by diabetic patients
undergoing gastric bypass operations for obesity. Up to
90% of these patients experience early remission of diabe-
tes, independent of weight loss (whereas a similar weight
loss alone can only explain a slow remission in up to 50%),
and several studies have pointed to an exaggerated secre-
tion of GLP-1 as an explanation for this (228,229). Inter-
estingly, the human GLP-1 analogue, liraglutide, was given
to a large group of non-diabetic overweight/obese subjects,
of which one-third were glucose intolerant, for 20 weeks.
During therapy (which led to significant and durable
weight losses) glucose tolerance was normalized in 90% of
participants (63).
Conclusions
A large set of data going from the underlying mechanisms
to long-term intervention studies support the role of a
decrease in postprandial glycaemia in the prevention of
diabetes. However, data are still lacking on which profile of
the postprandial glycaemic response may be more favour-
able. More short-term interventions with careful control of
these parameters are, therefore, still required.
Elevated blood glucose, concomitantly with elevated
insulin concentration, leads to a transitory deleterious
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metabolic and hormonal state and oxidative stress, involv-
ing the liver, the pancreas, skeletal muscles, lipid metabo-
lism interactions as well as incretins and inflammatory
parameters in healthy subjects. These phenomena are exac-
erbated in participants with IGT. Some but not all studies
have shown that reducing blood glucose and insulin
responses is beneficial for preventing T2DM in at-risk sub-
jects. However, based on the published literature, several
clinical trials (short- and long-term) were excluded from
the analysis because they failed to obtain significant differ-
ences in post-meal blood glucose responses. In fact, several
studies using theoretically LGI vs. high-GI diets did not
achieve differences in blood glucose response. One of the
main issues is that the diet has to be well controlled and
well selected to be able to provide a low glucose response
via modifying the quality of carbohydrates, or by the addi-
tion of some soluble viscous fibres or other relevant diet/
food manipulation. Thus, one of the challenges in clinical
experiments, and moreover in ‘real life’, is to provide really
low-glucose response diets. Then, there is a need for addi-
tional well-designed studies to confirm the metabolic
impact of lowering blood glucose response concomitant
with a low insulin response in healthy subjects.
Cardiovascular prevention4
Postprandial/post-challenge blood glucose and
CVD in healthy people
The relationship between blood glucose levels and CVD in
patients with T2DM has been well established by several
epidemiological studies (230,231). However, the cardiovas-
cular effects of intervention studies aiming at blood glucose
optimization have not always given satisfactory results
(232). Much of the epidemiological evidence (233,234) and
some intervention studies in T2DM patients (235) support
the role of postprandial blood glucose levels as an indepen-
dent cardiovascular risk factor. The relationship between
postprandial and fasting blood glucose, on the one hand,
and cardiovascular risk, on the other, is more controversial
in non-diabetic patients. First of all, it should be underlined
that in relation to the postprandial phase, only data regard-
ing post-challenge (i.e. 2 h after an oral glucose tolerance
test [OGTT]) and not postprandial blood glucose levels are
available, except for one study discussed later in this chapter.
It is clear that these two metabolic conditions, although
interrelated (236), are substantially different and, therefore,
data based on post-challenge blood glucose should be
extrapolated to post-meal blood glucose with caution.
The relationship between post-challenge blood glucose
and cardiovascular risk in non-diabetic patients has been
investigated in many prospective studies and reviewed in
some meta-analyses (237,238). The largest meta-analysis
by Levitan et al. (238) included 13 studies with post-
challenge blood glucose data. This meta-analysis showed
that
1. Both fasting and post-challenge blood glucose levels
are significantly and independently related to cardiovascu-
lar risk in the non-diabetic glucose range.
2. The cardiovascular risk appears similar for fasting
and post-challenge blood glucose levels, with 27% greater
risk in individuals with the highest post-challenge blood
glucose levels (150–194 mg dL-1) vs. those with the lowest
ones (69–107 mg dL-1).
3. The relationship between post-challenge blood
glucose levels and CVD seems to be continuous, at odds
with that for fasting blood glucose, which seems to have a
threshold at 100 mg dL-1. However, a minority of studies
also show a threshold relationship for post-challenge blood
glucose (239–245).
4. The relationship with both fasting and post-challenge
blood glucose remains significant, although not equally
strong, after adjusting for the main cardiovascular risk
factors.
These data have been confirmed by the results of two
more recent studies. One is a population study on a large
number of men and women, which showed that both
fasting and post-challenge blood glucose levels, even in a
non-diabetic range, were significant and independent pre-
dictors not only of cardiovascular mortality but also of
total mortality and that, also in this population, the type of
relationship with post-challenge blood glucose levels was
continuous (246). The other study showed that, even
among individuals with both fasting and 2 h post-challenge
blood glucose within the normoglycaemic range (i.e. indi-
viduals without impaired fasting glucose or IGT), those
whose post-challenge blood glucose levels did not return to
their fasting levels had a higher cardiovascular mortality
than those whose post-challenge blood glucose returned to
fasting levels (247).
The possible role of post-challenge glycaemia in deter-
mining a higher atherosclerotic risk has been investigated
also in relation to surrogate markers of CVD, in particular
to intima-media thickness (IMT). Studies indicate that
post-challenge blood glucose levels in non-diabetic indi-
viduals are significantly associated with higher IMT inde-
pendently of, and stronger than, fasting blood glucose
levels (248,249). In one of these studies that evaluated
different parameters during OGTT, 2 h post-challenge
levels and 2 h post-challenge spikes (the difference between
the maximal post-challenge glucose level and the fasting
level) were significantly related to IMT; however, in the
multivariate analysis only 2 h post-challenge levels
remained significant (249). Unfortunately, a group of newly
4The main authors of this section are Angella Rivellese and Lutgarda
Bozzetto.
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discovered individuals with T2DM were also included in
this study, which prevented a clear conclusion about the
role of post-challenge blood glucose levels in a non-diabetic
range. All the principal prospective studies evaluating the
relationship between post-challenge blood glucose and
CVD in non-diabetic individuals are reported in Table 6.
The only study performed measuring post-meal blood
glucose has been carried out in participants with coronary
artery disease. In this study postprandial blood glucose
levels between 140 and 199 mg dL-1 were not associated
with an increased cardiovascular risk (250). In conclusion,
on the basis of the available epidemiological studies, there
seems to be an independent association between post-
challenge blood glucose and CVD in both non-diabetic men
and women. However, it is not clear to which extent higher
levels of this post-challenge as well as of fasting blood
glucose levels in a non-diabetic range may help identify
people at increased cardiovascular risk. In any case,
because the relationship does seem to exist, it is important
to (i) clarify the plausible underlying mechanisms of this
association and (ii) to see whether any intervention studies
are able to prove a causal relationship.
Different mechanisms may link non-diabetic hypergly-
caemia with atherogenesis (251). Increased levels of non-
diabetic post-challenge blood glucose generally identify
people with IGT and/or other metabolic abnormalities
such as overweight/obesity, insulin-resistance, higher levels
of blood pressure, fasting and postprandial lipid abnor-
malities. Each of these metabolic abnormalities increases
cardiovascular risk per se (252,253). However, the relation-
ship between non-diabetic post-challenge hyperglycaemia
and CVD is only partly explained by these other risk
factors because it remains significant after also adjusting
for these factors (238). Therefore, other mechanisms more
strictly linked to hyperglycaemia per se should play a role,
such as non-enzymatic glycosylation of proteins, increased
glucose metabolism through the polyol and glucosamine
pathways, and generation of free radicals, which could
represent the unifying mechanism of hyperglycaemia-
induced tissue damage (for more details on these points
refer to other sections).
Intervention studies able to prove a cause–effect relation-
ship are extremely rare. In the STOP-NIDDM trial
in people with IGT, the administration of acarbose,
which delays absorption of carbohydrates in the small
intestine, resulting in more carbohydrates being subject to
fermentation in the colon, resulted in a significant 49% RR
reduction of overall cardiovascular events, which, however,
were only secondary objectives of the study (3) (Table 7).
The reduction in cardiovascular events was ascribed to a
decrease in postprandial blood glucose levels, which were
not measured in the study. However, the release of GLP-1
stimulated by acarbose may have also positively influenced
cardiovascular risk. Very recently the NAVIGATOR study
has shown that nateglinide, a drug able to reduce postpran-
dial blood glucose, was unable to decrease cardiovascular
events in a population at high risk of diabetes (197)
(Table 7). As also indicated in the section ‘Prevention of
diabetes and IR’ in this article, the difference between the
two studies could be due to the different mechanisms of
action of acarbose (decrease in postprandial blood glucose
by delaying carbohydrate absorption) and nateglinide
(decrease in postprandial blood glucose by enhancing first-
phase insulin secretion) or, more simply, to the fact that in
the NAVIGATOR study, nateglinide was actually not able
to reduce postprandial blood glucose levels.
Modulation of postprandial blood glucose
response by different types of carbohydrates and
its relationship with cardiovascular risk
As increased postprandial/post-challenge blood glucose
levels are an independent cardiovascular risk factor, even in
a non-diabetic range, it is important to modulate postpran-
dial blood glucose in everyday life at the population level in
order to reduce cardiovascular risk. It is well known that
both the quantity and the quality of carbohydrates – best
represented by theirGI and/orGL – are themainmodulators
of postprandial blood glucose concentrations; it is, there-
fore, necessary to examine the data linking dietary GI/GL
with (a) CVD or (b) the main cardiovascular risk factors.
(a) In the Nurses Health Study, Liu et al. (254) found a
significant positive association between dietary GL and
the risk of coronary artery disease after adjustment
for known confounders, especially in women with a
BMI > 30 kg m-2. This result has been confirmed by a
recent study in women (255) but not by two other studies
in men (256,257). However, in one of the latter studies a
significant association was found in the group of men
over 60 years with a BMI greater than 25 kg m-2. There-
fore, a low GL, which can be due to a low carbohydrate
content and/or to a higher intake of LGI foods, may be
more beneficial in terms of cardiovascular risk in over-
weight people, who are at higher risk for diabetes and
CVD. Data from a meta-analysis of observational studies
confirm that diets with a high GI or GL independently
increase the risk of heart disease (by 25%) and other
chronic diseases (T2DM, breast cancer and gall bladder
disease), showing that overall, the magnitude of the asso-
ciation was greater for GI than for GL (124). The data
rom this meta-analysis are based on a population largely
represented by women; therefore, these findings cannot be
generalized to men. In this respect, results from a large
cohort of Italian people confirm that a high dietary GL
and, in particular, carbohydrates from high-GI foods
increase the risk of CHD in women but not in men (258).
Among the different types of carbohydrates, dietary fibre,
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Table 6 Epidemiological studies evaluating the association between post-challenge blood glucose (2 h after 75 g glucose load) and cardiovascular
disease in non-diabetic people
a. Studies comparing top and bottom categories of blood glucose
Reference Participants
(n)
Follow-up
(year)
Age
(year)
Men
(%)
Cardiovascular
outcome
RR (CI)
Vaccaro et al. (1992) (441) 838 19 34–65 100 CVD mortality 1.96 (1.11  3.45)
Fujishima et al. (1996) (240) 2,167 5 40–79 43 CVD mortality 1.9 (1.2  3.2)
Park et al. (1996) (241)
Men 549 8 55–90 100 CVD mortality 0.83 (0.47  1.45)
Women 690 8 55–92 0 CVD mortality 1.01 (0.51  2.00)
Lowe et al. (1997) (239)
Black 594 22 35–64 100 CVD mortality 1.17 (0.66  2.1)
White 9,830 22 35–64 100 CVD mortality 1.04 (0.91  1.19)
Balkau et al. (1998) (242) 10,025 20 44–55 100 CVD mortality 1.08 (0.79  1.50)
Rodriguez et al. (1999) (243) 6,514 23 48–68 100 CHD incidence 1.08 (1.11  3.45)
Tominaga et al. (1999) (442) 2,398 6 40 44 CVD mortality 2.22 (1.08  4.58)
DECODE Study Group (443) (2001)
Men 14,376 8.8 30–89 100 CVD mortality 1.34 (1.12  1.60)
Women 6,686 8.8 30–89 0 CVD mortality 1.28 (0.88  1.86)
Sayadah et al. (2001) (244) 3,092 16 30–74 46 CVD mortality 0.93 (0.57  1.51)
Smith et al. (2002) (245) 4,014 8.5 65 40 CVD incidence 1.90 (1.51  2.39)
Nakagami (444) (2004) 6,817 10 30–89 45.7 CVD mortality 1.27 (0.86  1.88)
Wild et al. (2005) (445) 1,496 15 55–74 50 CVD mortality 1.08 (0.34–3.40)
Pankow et al. (2007) (446) 6,888 6.3 52–75 42 CHD incidence 0.83 (0.59–1.17)
Wang et al. (2007) (447) 1,025 13 65–74 36.2 CVD mortality 1.55 (1.17–2.05)
Barr et al. (2007) (448) 10,428 5.2 58 40.7 CVD mortality 1.5 (1.1–2.05)
Chien et al. (2008) (449) 2,165 10.5 >35 44 CHD incidence 2.05 (1.23–3.42)
Succurro et al. (2009) (248)* 400 – 21–70 44.7 IMT P = 0.006
Cedeberg et al. (2010) (246) 593 10 61–73 41.3 CHD Incidence
or CVD mortality
1.65 (1.19–2.30)
Ning et al. (2010) (247)
Men 12,563 9 25–90 100 CVD mortality 1.22 (1.05–1.41)
Women 10,877 9 25–90 0 CVD mortality 1.40 (1.03–1.89)
b. Studies evaluating linear relationship of post-challenge blood glucose with CVD
Reference Participants
(n)
Follow-up
(y)
Age
(y)
Men
(%)
Cardiovascular
Outcome
RR (CI)
Orencia et al. (1997)* (450)
Men aged 18–39 10,269 22 18–39 100 CVD mortality 1.11 (0.97–4.26)
Men aged 40–59 7,993 22 40–59 100 CVD mortality 1.09 (1.04–1.14)
Men aged 60–74 1,240 22 60–74 100 CVD mortality 1.05 (0.96–1.14)
Women aged 40–59 6,319 22 40–59 0 CVD mortality 1.10 (1.00–1.21)
Women aged 60–74 932 22 60–74 0 CVD mortality 1.18 (1.06–1.31)
De Vegt et al. (1999) (451) 2,199 8 50–75 46 CVD mortality 2.24 (1.70–2.94)
Temelkova-Kruscev et al. (2000) (249)† 582 – 40–70 47.7 IMT 1.50 (1.08–2.10)
Agewall (2001) (452) 113 6.3 50–72 100 CVD mortality 1.56 (1.03–2.48)
Meigs et al. (2002) (453) 3,370 4 26–82 46 CVD Incidence 1.18 (1.10–1.27)
Stern et al. (2002) (454)
Men 1,693 7.5 25–64 100 CVD incidence 1.35 (1.16–1.57)
Women 2,209 7.5 25–64 0 CVD incidence 1.31 (1.11–1.54)
Barr et al. (2009) (455) 10,026 7 25 45.2 CVD mortality 1.2 (1.0–1.2)
*1 h after 50 g glucose load.
†Postprandial glucose spikes (difference between the maximal PG level during OGTT, irrespective of the time after glucose challenge, and the level
of FPG).
CHD, coronary artery disease; CI, confidence interval; CVD, cardiovascular disease; FPG, fasting plasma glucose; IMT, intima-media thickness;
PG, postprandial glucose; RR, relative risk.
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one of the main contributors to the LGI and GL of a diet,
is essential in the modulation of postprandial blood
glucose and in the decrease of other main cardiovascular
risk factors (such as LDL cholesterol, both fasting and
postprandial plasma TGs, and blood pressure) (259–261).
On the basis of these multiple beneficial effects, a signifi-
cant inverse relationship has been found between the
intake of dietary fibre, both soluble and insoluble, and
CHD mortality (262–264). The studies evaluating the
association between GI, GL, fibre intake and CVD in
non-diabetic people are summarized in Table 8.
(b) With respect to the association between GI/GL and
the main cardiovascular risk factors, epidemiological evi-
dence shows
1. An inverse relationship between the GL/GI of the
diet and the level of HDL cholesterol in different countries
and population groups (186,265,266).
Table 7 Intervention studies evaluating the effect of postprandial blood glucose reduction on CVD
Study Participants Study design Intervention Follow-up
(year)
Cardiovascular outcome Effects
Chiasson et al.
(2003) (3)
1,368 (n)
with IGT
International multicentre
randomized, double
blind, trial
Acarbose x3 die vs.
placebo
3.3 CHD incidence ↓
NAVIGATOR trial
(2010) (197)
9,306 (n)
with IGT
Randomized, double blind,
trial; 2-by-2 factorrial design
Nateglinide + Valsartan
vs. placebo
5 CVD mortality and incidence =
CHD, coronary artery disease; CVD, cardiovascular disease; ↓, reduced incidence; =, no effect.
Table 8 Epidemiological prospective studies evaluating the association between dietary glycaemic index, load and fibre intake with CVD
Study Participants
(n)
Follow-up
(year)
Age
(year)
Men
(%)
Cardiovascular
outcome
Risk in highest vs. lowest quantile
GL GI Fibre
intake
Liu et al. (2000) (254) 75,521 10 38–63 0 CHD incidence ↑ ↑ NE
Eshak et al. (2010) (263) 58,730 14 40–79 CVD mortality NE NE ↓
Van Dam et al. (2000) (456) 394 10 64–84 100 CHD incidence NE = NE
Bazzano et al. (2003) (262) 9,776 19 25–74 CHD incidence NE NE ↓
Oh et al. (2005) (457) 78,779 18 30–55 0 Stroke incidence ↑ if BMI > 25 = ↓
Ischaemic = ↑ if BMI >25 =
Haemorrhagic = = ↓
Beulens et al. (2007) (255) 15,714 9 49–70 0 CVD incidence ↑ ↑ NE
Levitan et al. (2007) (256) 36,246 5 45–79 100 CVD mortality = = NE
CHD incidence = = NE
Ischaemic stroke
incidence
= = NE
Haemorrhagic
stroke incidence
↑ = NE
Wolk et al. (1999) (264) 68,782 10 37–64 0 CVD mortality or
CHD incidence
NE NE ↓
Mursu et al. (2009) (257) 1,981 16.1 42–60 100 CHD incidence ↑ if BMI > 25 and/or
low physical activity
↑ if BMI > 25 NE
Levitan et al. (2010)* (458) 4,617 6 45–79 100 CVD mortality = = NE
Hardy et al. (2010) (459) 13,051 17 45–64 CVD incidence ↑ ↑ NE
Ischaemic = = NE
Grau K et al. (2010) (462) 2,790 6–25 30–70 50.7 CHD incidence
Women = = NE
Men ↓ = NE
*In people with previous CVD.
BMI, body mass index; CHD, coronary artery disease; CVD, cardiovascular disease; GI, glycaemic index; GL, glycaemic load; NE, not evaluated; ↑,
increased risk; ↓, reduced risk; =, no association.
952 Postprandial glycaemia and health E. E. Blaak et al. obesity reviews
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity13, 923–984, October 2012
2. A positive association between the GL/GI of the diet
and the concentration of fasting TGs, and this relationship
is stronger in people with a higher BMI (186).
3. A high GI or GL influenced the development of the
metabolic syndrome in the Framingham Offspring Study
(267)
4. IR was associated with increasing GI in the
Framingham Study but not in other studies (268,269).
Which mechanisms may explain the above associations?
Diets with a high GI/GL and, in particular, with high GI
and low fibre are associated with higher blood glucose
levels, especially in the postprandial phase, and higher
insulin demand, which leads to hyperinsulinaemia mainly
in non-diabetic patients. Both higher blood glucose and
insulin concentrations may lead to increased cardiovascular
risk either directly or indirectly through the association
with other cardiovascular risk factors such as hypertriglyc-
eridaemia, low HDL cholesterol levels, hypertension and
hypercoagulability. Thus, there is enough epidemiological
evidence that diets with a high GL and/or a high GI may be
detrimental in relation to CVD, and plausible mechanisms
have been singled out.
However, epidemiological evidence must be supported
by intervention studies. Unfortunately no intervention
study has yet evaluated the effects of diets with different
GL/GI and/or different amounts of dietary fibre on cardio-
vascular events. Many studies have evaluated, instead, the
effects of these types of dietary intervention on postpran-
dial blood glucose, insulin levels/IR, subclinical inflamma-
tion and oxidative stress (these issues are treated in other
parts of the section). With respect to other cardiovascular
risk factors, it is also clear that diets low in GL/GI and/or
rich in dietary fibre are able to reduce LDL cholesterol,
postprandial TG-rich lipoproteins and blood pressure in
both diabetic and non-diabetic people. Moreover, in
healthy subjects, LGI foods have been shown to produce a
so called ‘second meal effect’ with improvement in post-
lunch glucose, insulin and TG levels after a breakfast con-
taining LGI foods compared with after a breakfast with
high-GI foods (270).
Conclusions
Epidemiological evidence indicates an independent rela-
tionship between post-challenge blood glucose levels and
CVD in both diabetic and non-diabetic people, and this
relationship seems to be continuous, i.e. without any real
threshold. These data may be extrapolated with some
caution to postprandial blood glucose levels for which, at
the moment, there is no direct evidence.
The direct association between high-GI/GL diets, able to
increase postprandial blood glucose, and CVD seems to
support the role of postprandial blood glucose levels as an
independent cardiovascular risk factor. It must be consid-
ered, however, that LGI diets, particularly if rich in dietary
fibre, may also reduce cardiovascular risk through their
action on other risk factors, especially LDL cholesterol and
SCFA formation, during fermentation in the colon.
Finally, we need conclusive evidence, possibly from spe-
cific intervention studies with cardiovascular outcomes. In
the meanwhile, our present knowledge is certainly enough
to suggest LGI foods, particularly those rich in dietary
fibre, as one of the components of a healthy dietary pattern
for the prevention of CVD.
Postprandial glycaemia and physical activity5
Depending on exercise intensity and duration, physical
work may have profound effects on the utilization of
glucose as a fuel in muscles. During low-grade intensity
exercise, postprandial glucose levels are very similar to
those during rest in both trained and untrained individuals
who show similar metabolic responses following high-
glycaemic or low-glycaemic foods. However, during inten-
sive muscle contractions an enhanced glucose uptake from
the blood will occur and thus the rate of ‘glucose disap-
pearance’ from the circulation after a meal preceding exer-
cise or, taken during exercise, will be enhanced. The effects
of muscle contraction on glucose uptake from the blood are
distinct from the effects of insulin and are known to con-
tinue even for many hours post-exercise. These effects of
exercise lead to both a reduced post-exercise need for
insulin production as well as to an enhancement of insulin
sensitivity. Because of these observations, regular exercise is
recommended as an important measure to manage post-
prandial blood glucose within ‘more healthy levels’ in
patients suffering from T2DM. In the next paragraphs the
effects of exercise on postprandial glucose regulation and
utilization will be described.
Role of carbohydrate stores and glucose
availability during exercise
It is well established that maintaining a high glucose
availability by consumption of carbohydrate during
high-intensity exercise as well as ultra-endurance events
can delay fatigue and thereby improve physical as well as
mental performance (271–275). As intensive exercise
induces hormonal, metabolic and circulatory changes that
impact significantly on the fate of postprandial glucose and
lipid metabolism, it is important to understand the differ-
ences from resting conditions. Carbohydrate, by means of
glucose availability, is the most important fuel for high-
intensity muscular work. During exercise, the muscle uses
glucose taken up from the blood as well as that obtained
5The main authors of this section are Fred Brouns and Stephan Theis.
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from glycogen in muscle cells. In the body, glucose is stored
as glycogen in the liver and in the muscle. The amount of
glycogen stored in the liver amounts to approximately
100 g. This quantity may change periodically, depending
on the amount of glycogen that is broken down for the
supply of blood glucose, in periods of fasting and the
amount of glucose that is supplied to the liver after food
intake. Accordingly, liver glycogen reserves increase post-
prandially but diminish in between meals, especially during
the night, when the liver constantly delivers glucose into the
bloodstream to maintain a normal blood glucose level
(276–280). During physical exercise, metabolic and hor-
monal stimuli as well as muscle contraction-induced stimuli
will lead to an increased uptake of glucose from the blood.
To avoid the blood glucose level falling below normal, the
liver is stimulated to degrade glycogen for the delivery of
glucose to the bloodstream. Thus, appropriate glucose
storage in the liver is a key factor for the maintenance of a
normal blood glucose level during prolonged exercise. Lack
of liver glucose output may cause glucose to fall to hypogly-
caemic levels and fatigue may develop. The amount of
glucose that is stored in total muscle glycogen in the body
amounts to approximately 300 g in sedentary people and
may be increased to >500 g in trained individuals by a
combination of exercise and the consumption of a
carbohydrate-rich diet (276,281,282). The total intramus-
cular stored glucose, in energetic equivalent, may thus
range from 1,200 to 2,000 kcal. The rate at which glucose
is mobilized from muscle glycogen as a fuel for muscle
contraction depends on a range of factors of which acute
changes in energy requirements (exercise intensity) and
availability of glucose and fatty acids for energy delivery
are the most important. A very small pool of energy-rich
phosphates (ATP and CP) is immediately available for
muscle contractions at any moment of suddenly increased
energy need, e.g. a sprint. These sources deliver most of the
required energy for a period of up to maximally 10–15 s.
For any longer-lasting events, the energy requirements will
have to be covered almost completely by metabolism of
glucose and fatty acids (276,279–281,283–285). The use of
any of these two will never be exclusive. Thus, at any time
muscle will use a mixture of carbohydrate and fat (and
also, to a small degree, some protein). The most important
factors that determine the relative contribution of carbo-
hydrates, fat and aminoacids to the fuel mix and the rate
and the extent to which macronutrient stores will be uti-
lized are (i) exercise intensity and duration; (ii) training
status and (iii) macronutrient ingestion.
Exercise intensity and duration
At rest most of the actual energy needs in muscle tissue will
be derived from fat. In this situation the possible energy
supply ratio may be in the order of 90% from fat and about
10% from carbohydrates. During a situation of increased
physical activity, i.e. light physical work, or a moderately
intensive sports activity, the body will use metabolic,
hormonal and nervous control mechanisms to mobilize
glucose from glycogen pools to serve as a rapidly available
energy source (286). Synchronically an elevated mobiliza-
tion of fatty acids will be initiated. After some time a
new metabolic steady state will be achieved in which the
energy supply ratio of fat to carbohydrates may then, for
example, be about 50% : 50%. Thus, a gradual shift from
high-fat/low-carbohydrate utilization at rest to enhanced
carbohydrate/reduced fatty acid utilization during physical
activity takes place. The absolute and relative contribution
of carbohydrates and fatty acids to the fuel supply is influ-
enced not only by exercise intensity but also by duration.
Fat oxidation increases and carbohydrate oxidation
decreases as the exercise duration increases. Typical fat
oxidation rates are between 0.2 and 0.5 g min-1, but values
of over 1.0–1.5 g min-1 have been reported after 6 h of
running. The contribution of fat to energy expenditure can
even increase to as much as 90% (287). With increasing
work intensities, the body will start to use more and more
carbohydrates as fuel. Accordingly, during all-out sports
activity events lasting 1–3 min, carbohydrate will become
the most important fuel (282,288,289). The reason for this
shift to the dominant use of carbohydrate is that the
amount of oxygen required for energy production from
carbohydrates is about 10% lower than that of fat (290).
Such a fine-tuned regulation of energy-rich substrate selec-
tion enables athletes to work at a higher intensity when
using carbohydrates as the main energy source. Indeed,
several lines of evidence show that intense and lasting
muscle work cannot be performed without appropriate
availability of carbohydrates and that athletes perform
longer at high exercise intensity when glucose availability
remains high (276,280,281,288,291). As such there is
general consensus about the impact of glucose availability
and the role of carbohydrate consumption during exercise.
The authors of a very recent meta-analysis review con-
cluded, based on 73 studies and 122 estimates, that the
performance effects of carbohydrate supplements ranged
from clear large improvements of ~6% to clear moderate
impairments of ~2%. The best supplement inferred from
the analysis consisted of a ~3–10% carbohydrate plus
protein drink providing ~0.7 g kg-1 h-1 glucose polymers,
~0.2 g kg-1 h-1 fructose and ~0.2 g kg-1 h-1 protein (292).
Training status and gender
During high-intensity exercise, the time course of glycogen
depletion will be influenced by the training status of the
individual. Compared with less well-trained individuals,
highly trained individuals have an improved capacity to
mobilize fatty acids as a fuel. Thus, when working at a high
but same absolute exercise intensity (e.g. running at a speed
of 15 km h-1), trained individuals will use less carbohy-
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drate and more fat for muscle contraction (284,293). At
lower exercise intensities training status plays less of a role
(294). Likewise, studies with trained and untrained seden-
tary individuals found similar metabolic responses follow-
ing high-glycaemic or low-glycaemic foods and similar
differences in substrate metabolism at rest and during low-
to moderate-intensity exercise (295). Gender may impact,
however, on substrate utilization in that greater fatty acid
mobilization occurs in females during prolonged exercise
compared with males. The reverse, however, is observed
during the recovery phase, which may explain why, despite
mobilizing lipids to a greater extent than males during
exercise, females lose less fat mass than their male counter-
parts over the course of a physical training programme
(296).
Postprandial glucose and type of
carbohydrates consumed
The postprandial effects during exercise as well as the
relative contribution of the individual substrates in the
fuel mix used during physical activity depend on various
factors, including the amount of carbohydrate ingested,
the timing of intake and the intensity and duration of
exercise (297). Generally, a high-postprandial blood
glucose response following carbohydrate ingestion prior
to exercise has large effects on insulin response, fat mobi-
lization and substrate utilization during the onset of exer-
cise. Lipolysis and fatty acid availability is suppressed,
inducing a reduction in fat oxidation (287,298,299).
Carbohydrate intake during exercise also inhibits fat
oxidation by hindering the transport of fatty acids into
the mitochondria (297). A lower postprandial blood
glucose response as obtained following slowly digestible
carbohydrate ingestion prior to and during exercise
results in an accordingly lower rise in insulin levels and
consequently in the maintenance of a higher rate of fat
oxidation (298–301). Higher availability of fatty acids for
oxidation, in turn, can cause a decrease in the rate of
muscle glycogen breakdown (297). Further details on the
metabolic effects of carbohydrate ingested during exercise
and postprandial glycaemia, in particular on insulin
release, absorption and oxidation during physical activity,
are addressed below.
Effect of postprandial glycaemia on substrate
utilization and working capacity
Intake of carbohydrates reduces glycogen degradation
At low exercise intensities, the rate of utilization of glucose
from stored glycogen in the body can be reduced by the
consumption of carbohydrate. Any increase in blood
glucose after oral carbohydrate intake reduces the need to
break down liver glycogen for the maintenance of an
appropriate blood glucose level. The reduction of liver
glucose output equals the rate at which glucose is supplied
to the blood from the intestine (302). The increase in blood
glucose after carbohydrate intake during exercise will
enhance glucose uptake by the muscle as well as subsequent
carbohydrate oxidation. Several lines of evidence suggest
that these events will help reduce the rate of muscle glyco-
gen degradation (303–310).
As glycogen depletion and related falls in blood glucose
during endurance exercise rarely take place when exercise
duration is <30–45 min, guidelines for carbohydrate inges-
tion during exercise are primarily given for durations
exceeding 45 min. Thus, for exercise lasting longer than
45 min it is recommended that at least 20 g, but optimally
up to 60 g, be consumed, with sufficient fluid, for every
next hour of exercise (288,311).
Carbohydrate types determine rate of
glucose availability
The source and the molecular structure of carbohydrate
will determine its rate of digestion, absorption and subse-
quent fate in metabolism. For example, foods that are
rich in viscous dietary fibres delay gastric emptying and
impact on intestinal viscosity, resulting in a reduced rate of
digestion and absorption of glucose into the circulation.
This would be a disadvantage in any condition requiring
high glucose availability, such as during intensive physical
endurance work. Several studies have addressed the effect
of high- vs. low-glycaemic carbohydrate feeding on sub-
strate and glycogen utilization. Generally it was observed
that pre-exercise carbohydrate feeding with high-GI
carbohydrates facilitates carbohydrate utilization during
exercise (312,313). Studies have shown that different car-
bohydrates consumed during exercise are emptied from the
stomach and are absorbed at different rates in the gut,
while osmolarity does not play an important role at low
carbohydrate concentrations as usually consumed during
exercise (314–316). The intestinal absorption rate will
strongly affect the glycaemic and insulinaemic responses
and uptake in tissues, thus the availability for energy
metabolism. For example, glucose is rapidly absorbed and
oxidized compared with fructose and galactose, which are
less readily absorbed (306,317,318). Incomplete absorp-
tion of carbohydrate ingested during exercise may lead to
intestinal side effects due to carbohydrate accumulation in
the intestine whenever the supply exceeds the rate at which
the carbohydrate is absorbed. Some authors have reported
intestinal upset when >30 g L-1 fructose has been ingested,
both at rest and during exercise (319). However, in one
study, this effect with ingestion of up to 1 g kg-1 body
weight during exercise (320) was not found. Additionally,
the rate of fructose utilization as a fuel during exercise has
been shown to be lower. This may be caused by various
events such as relatively slow fructose absorption, a signifi-
cant metabolism of fructose during its first pass through the
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liver and by the fact that the enzyme hexokinase muscle
has a much higher affinity for glucose than for fructose
(303,304,311,318,319).
Factors that affect the rate of oxidation of ingested car-
bohydrates during exercise include feeding schedule, type
and amount of carbohydrates ingested, and the exercise
intensity. Glucose is a carbohydrate that is oxidized quickly
as it needs no digestion and is rapidly absorbed. Also, and
glucose polymers (MDX) are known to be oxidized at rates
of 0.45–1.16 g min-1 (321). Simultaneous ingestion of
glucose and fructose may even result in oxidation rates of
1.5–2.4 g min-1, possibly reflecting different absorption
routes resulting in a higher quantitative supply rate to
blood (321–323). Accordingley, it has been shown that a
combination of glucose and fructose can impact more
favourably on physical work capacity compared with
glucose alone (324).
Recently, some studies have been addressing the post-
prandial glycaemic and insulinaemic effect of the disac-
charides ISO (gluc-fruc) and trehalose (TRE) (gluc-gluc).
ISO and TRE are both disaccharides suggested to be
slowly digested, resulting in a slow rate of absorption. In
a study by Achten et al. (300), it was found that ingesting
ISO every 15 min during a 2.5-h exercise trial of moder-
ate intensity resulted in a lower plasma insulin response
at 30 min compared with SUC, while the blood glucose
response did not differ between ISO and SUC. Mean and
peak oxidation rates of ingested ISO were significantly
lower than that of SUC and resulted in a higher fat oxi-
dation. In another study, TRE ingestion, compared with
glucose, also resulted in lower insulin and blood glucose
levels (325). In a follow-up study (301) TRE was com-
pared with maltose (MAL) and a water placebo. TRE
oxidation was lower than the MAL oxidation rate and
total fat oxidation tended to be lower in MAL compared
with TRE (P < 0.06). The reduced exogenous carbohy-
drate oxidation rate of TRE compared with MAL was
assumed to be due to a reduced digestion rate in the small
intestine, causing a slower availability for absorption.
These data support the notion that the type of carbohy-
drate consumed impacts on substrate availability and oxi-
dation rate.
Dietary starches. Some researchers have specifically
studied the rates of postprandial glucose oxidation from
various starch types. This is possible by using starch that
is naturally enriched with Carbon 13 (corn starch) or
by adding a C13 glucose tracer to starch. Both methods
have their limitations. C13 starch studies are difficult to
perform in US populations because their high consump-
tion of cornstarch-containing products causes high levels
of endogenous C13 enrichment of glycogen and also fat
depots. In a European population this is less of a problem
(326). Alternatively a C14 glucose label can be added
(327). Adding a C13 or a C14 label to a starch in order to
quantify the rate of oxidation of the label and assume that
this equals the rate of starch oxidation is a practice that
has been used. It has also been assumed that the rate of
digestion of starch is non-limiting and that glucose derived
from starch digestion behaves similarly to the glucose
label added (327). However, Saris et al. (316) were able to
show that this leads to an overestimation of the oxidation
rate. Accordingly, appropriate measures of postprandial
starch oxidation can only be obtained using intrinsically
labelled starch. This was performed by Guezennec et al.
(328), who compared the rates of oxidation of bread,
potatoes, rice, spaghetti and glucose, given as isocaloric
meals 1 h before exercise. Their study showed that the
glucose and insulin responses were as follows in descend-
ing order: glucose > potatoes > bread > rice > spaghetti.
The oxidation rate of spaghetti was lower than that of
glucose. The postprandial oxidation rate of gelatinized
amylopectin equalled that of glucose while a progressive
decline in oxidation rate was observed from gelatinized
amylose and crude amylopectin to crude amylose. These
data confirm earlier published data from van Amelsvoort
and Weststrate (329). From the hormonal and metabolic
data described above, it appears that the type of carbohy-
drate will determine its kinetic properties for use during
exercise. Thus, high exogenous carbohydrate oxidation
rates and a fast utilization can be achieved with carbohy-
drate sources that are easily and fully digestible and
absorbable, while lower postprandial blood glucose and
insulin responses are related to lower oxidation rates. This
is in line with recent observations that altering the GI
of the carbohydrate within a meal significantly changes
the postprandial hyperglycaemic and hyperinsulinaemic
responses in women. An LGI pre-exercise meal resulted in
a higher rate of fat oxidation during exercise than did an
HGI meal (295).
Postprandial macronutrient interactions influence the
metabolic fate of glucose
The metabolism of carbohydrate may also be influenced by
the presence of other macronutrients. For example, recent
studies have shown that a mixture of 0.8 g ¥ kg ¥ h carbo-
hydrate and protein or selected amino acids leads to a
significantly higher insulin response compared with the
ingestion of carbohydrate alone (330,331). This was
assumed to be of advantage in circumstances where a high
insulin level may be of benefit to the rate of uptake of
glucose in tissues. Accordingly it was observed that the
resynthesis rate of muscle glycogen after an exhausting
exercise proceeds more rapidly when such a combination is
ingested (331). However, at higher levels of carbohydrate
intake, i.e. 1.2 g ¥ kg-1 ¥ h-1, the stimulating effect of
insulin on glycogen recovery was not apparent anymore
(332,333).
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However, at higher levels of carbohydrate intake, i.e.
1.2 g ¥ kg-1 ¥ h-1, the stimulating effect of insulin on gly-
cogen recovery was not apparent anymore (332). Accord-
ingly, Cermak et al. (334) observed that when trained men
ingest carbohydrate at a rate at the upper end of the range
generally recommended to improve endurance perfor-
mance, co-ingestion of protein does not alter specific
markers proposed to reflect an enhanced capacity for
skeletal muscle energy delivery.
Postprandial glucose homeostasis during exercise
During physical activity the muscle does not solely rely on
insulin for the uptake of glucose (335–337). Muscle con-
tractions mobilize glucose transporters (GLUT 4) in a
similar way to insulin, but by a mechanism that is not yet
fully understood. It is likely to involve Ca(2+)-calmodulin-
dependent protein kinase, 5′-AMP-activated protein kinase
and possibly protein kinase (338). During intense physical
exercise this effect is explicitely required because muscle
activity causes an intensity-dependent inhibition of insulin
secretion through the action of the elevated catechola-
mines. This contraction-induced effect is referred to as
‘insulin-like action’, which may persist even for >12 h after
exercise has been stopped. Accordingly, a high intake of
carbohydrates during exercise may cause only a small
elevation of insulin in the case of high intensity or a strong
increase when exercise intensity is low. In the case that
carbohydrate is consumed shortly before exercise, the
combination of elevated insulin-induced glucose uptake +
muscle-induced glucose uptake action may cause reactive
hypoglycaemia because of muscle glucose uptake exceeding
liver glucose output. Some early studies showed that an
intake of 50–75 g of rapidly absorbable carbohydrate in a
fasted state and shortly prior to exercise induced a rapid
rise in blood glucose and insulin followed by a rebound
hypoglycaemia as well as decreased performance during
the subsequent exercise. However, these conditions may
be different from those of an endurance athlete, who
is advised to eat a pre-game breakfast and perform a
warm-up prior to the start of the competition. Studies done
under such real competition conditions with regular intake
of carbohydrate during exercise did not show any rebound
hypoglycaemia (339,340). In this respect, carbohydrate
intake during exercise will also counter affect pre-exercise
diet effects (341).
The occurrence of rebound hypoglycaemia may depend
on the timing of carbohydrate intake. In a recent study the
metabolic and performance responses to the ingestion of
75 g of glucose dissolved in 500 mL of water at differing
times before exercise were investigated (342). Altering the
timing of the ingestion of carbohydrate before exercise
resulted in differences in plasma glucose/insulin responses,
which disappeared within 10 min of exercise and which
had no effect on performance. Postprandial rebound
hypoglycaemia is independent of insulin sensitivity and
exercise intensity and does not occur in all individuals, i.e.
some individuals are more sensitive than others. Moreover,
if present, this condition is not always associated with
reduced performance capacity (342,343).
Immediate post-exercise carbohydrate intake
enhances physical recovery
Glycogen resynthesis has been shown to be most rapid
during the first few hours after exercise when muscle gly-
cogen is low, but only when carbohydrate has been con-
sumed to supply the required glucose (276,288,304,311).
The latter is influenced by the type of carbohydrate and its
rate of digestion and absorption. No difference appears
between males and females in their capacity to replenish
glycogen stores; optimal timing for carbohydrate intake
does not differ between genders, and athletes must
consume carbohydrates as soon as possible after exercise in
order to maximize glycogen store repletion (344).
Glucose favours muscle glycogen recovery, but fructose
is primarily taken up by the liver and favours liver glycogen
recovery (277,345,346). When the next activity takes
place, after 1 or 2 d, the athlete can recover properly by
ingesting normal meals with a high carbohydrate content,
i.e. 55–65 en% (en% = percentage of total daily EI). These
meals can best be composed of LGI foods such as whole
grains, cereals, pulses, fibre-rich fruits and vegetables. A
relatively slow digestion and absorption rate is favourable
in this condition. Sports practice and also controlled
experiments have shown that the high needs for energy and
carbohydrate during days with an energy expenditure
exceeding 4,500 kcal d-1 can only be covered appropriately
by the ingestion of rapidly digestible foods/beverages that
are high in carbohydrates (347–349). Carbohydrate solu-
tions can be taken during exercise in any situation in which
carbohydrate intake through the consumption of normal
food cannot take place or is insufficient. This will help to
enhance glycogen recovery in the first few hours after exer-
cise (304,311,350). Extensive reviews can be found in the
literature (271,292,296,344,351).
Postprandial carbohydrate metabolism and
cognitive performance6
Introduction
Diet-related disorders such as obesity (352) and T2DM
(353) are increasingly associated with cognitive decline
(463). The emerging knowledge in this area has generated
interest in the potential to prevent impairment of cognitive
6The main authors of this section are Inger Bjork, Louise Dye, Dan
Lamport and Anne Nilson.
obesity reviews Postprandial glycaemia and health E. E. Blaak et al. 957
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity 13, 923–984, October 2012
functions via choice of diet. Very little information is avail-
able concerning the long-term impact of different diets, and
to our knowledge no information is available concerning
the effects of dietary carbohydrate characteristics such as
the GI in this respect. However, recent reports suggest that
breakfast habits in children may influence brain grey-
matter volume and that children with a higher habitual
intake of rice (presumably LGI) display larger global grey-
matter volume than those with a higher habitual intake of
white bread (354).
With respect to acute studies regarding the effects of
macronutrients on cognitive measures, carbohydrates were
the most frequently studied and had the greatest positive
effects on verbal and delayed memory (355). Glucose forms
the major energy substrate for the brain and is fundamental
for normal functioning of the central nervous system. The
provision of glucose generally improves various measures
of memory function compared with placebo (356–358).
This facilitating effect is seen following the administration
of carbohydrates after overnight fasting and in between-
meal fasting situations (359). However, hyperglycaemia,
especially oscillatory excursions as may occur in the post-
prandial phase in the diabetic state, may trigger oxidative
stress and inflammation (360); see also the section on the
prevention of diabetes and IR in this article, suggesting a
potentially detrimental effect of high-GI foods.
Whereas high-GI foods are characterized by elevated
glycaemic responses of short duration, LGI foods typically
induce a lower peak response, and a more even and sus-
tained provision of glucose to the blood in the postpran-
dial period, hence counteracting hypoglycaemia which
may occur with high-GI foods in the later postprandial
phase (129,361). While the induction of hypoglycaemia in
healthy subjects results in significant impairment of cogni-
tion (362), less is known about the influence of glycaemic
excursions below fasting levels following the ingestion of
high-GI meals. Interestingly, changes in metabolite concen-
trations were suggested to be more important determinants
of cognitive function in the postprandial phase than their
absolute values (363,364), indicating benefits of a bal-
anced glucose metabolism and avoidance of oscillatory
glycaemia. The present summary discusses available litera-
ture concerning the potential impact of the course of post-
prandial glycaemia on measures of cognitive function
(Table 9).
Glucose and the brain
During cognitive effort, local extracellular concentrations
of glucose decline in the brain areas activated. Visual stimu-
lation can thus result in significant decreases in glucose
concentration in the visual cortex in humans (365), and
memory activation in rats causes reductions in hippocam-
pal glucose (366). An equilibrium exists between plasma
glucose concentrations and glucose in the extracellular fluid
such that the concentration of glucose in the brain is
20–30% of that in blood plasma (367–369). Therefore,
increasing plasma blood glucose levels results in a relative
increase in brain extracellular glucose levels (370,371).
This may enhance neuronal activity when brain extracellu-
lar glucose levels are depleted, which can occur as a result
of high neuronal activity (372) or because of abnormalities
in the transfer of glucose across the blood–brain barrier
(BBB). The BBB breaks down with age (373–375). There-
fore, when glucose in the extracellular fluid is reduced to a
level that results in neurons performing at a suboptimum
level, glucose consumption can facilitate neuronal activa-
tion. This mechanism could account for the observation
that glucose consumption aids cognition during periods of
high cognitive demand, and cognition is impaired in those
with IGT (376,377).
The synthesis of several key neurotransmitters in the
brain such as glutamate, gamma-aminobutyric acid and
acetylcholine relies on a supply of glucose. Acetylcholine
(from acetyl-CoA derived from glucose metabolism) and
choline increases synaptic plasticity, important for learning
and short-term memory. Also, glucose metabolism can
affect the utilization of tryptophan and may increase sero-
tonin concentration in the brain, hence affecting memory
and mood.
Cognitive functions in relation to glucose
regulation and IR
Insulin is absorbed in the brain by insulin receptors (378–
380) and areas of the brain, associated with learning and
memory express a high density of these receptors (367).
Therefore, a reduction of insulin in the brain or the pres-
ence of IR may cause neurons to be functionally insulin
deficient (381). Increases in hippocampal insulin receptor
expression and signalling are associated with improved
spatial memory performance (382), and impairments in
rodent hippocampal synaptic plasticity can be reversed by
insulin replacement (383). In humans, intravenous or intra-
nasal injections of insulin have been associated with
cognitive improvements in healthy adults (384,385) and
Alzheimer’s patients (386–388). Furthermore, experimen-
tal studies have shown that drugs that improve insulin
sensitivity (thiazolidinediones) are associated with cogni-
tive improvements (389).
The glucose transporters GLUT 4 and GLUT 8, found
throughout the brain, are also sensitive to insulin levels
(390,391). This suggests that insulin also affects the
transport of glucose within the brain. Chronic peripheral
hyperinsulinaemia, as occurs in IR, negatively influences
neuronal function and survival. Eventually, peripheral
hyperinsulinaemia results in a reduction of insulin
transport across the BBB and in reduced insulin receptor
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signalling, leading to reduced synaptic plasticity in the
brain with effects on learning and memory (392). IGT with
concomitant IR results in impaired cognitive functions
(393–395). However, reduced glucose tolerance within the
normal range can also be accompanied by impaired cogni-
tive performance (377,396–399). Oxidative stress plays an
important role in the pathogenesis of IR and beta-cell dys-
function. As oscillating hyperglycaemic episodes promote
oxidative stress (360), it can be suggested that elevated
postprandial glucose excursions could be detrimental for
IR signalling in the periphery, with potential impact also
centrally, and hence on cognitive function. Of interest, in
connection with this, are data showing that venous admin-
istration of insulin increases insulin levels acutely in the
cerebrospinal fluid (385). Also, exogenous administration
of insulin under euglycaemic conditions in healthy subjects
and subjects with Alzheimer’s disease acutely improved
measures of cognitive function (400). Hence, a habitual
diet that maintains insulin sensitivity and IR signalling, and
secures optimal glucose delivery to the brain in the fed and
fasting states should be most advantageous for the main-
tenance of cognitive function. The glycaemic potency of the
diet is of interest in this context. Studies are required to
examine IGT and cognitive function in the absence of other
comorbidities to determine the possible causal effect of IGT
on cognitive function.
Postprandial glucose metabolism in relation to
cognitive function
The effects of breakfast on the cognitive performance of
children and adolescents have recently been reviewed
(355). Young children might be expected to be more sus-
ceptible to effects of brief or overnight fasting because of
greater metabolic demands of the brain relative to liver and
muscle glycogen stores, and childrens’ lower capacity for
gluconeogenesis (401–403). Wesnes et al. (401) compared
the effects of consuming cereal breakfasts (Cheerios or
Schreddies), glucose or no breakfast on cognitive perfor-
mance in children (9–16 years). No glycaemic measure-
ments were performed, and the breakfast meals consumed
reflected realistic portion sizes. Consequently, about 38 g of
available carbohydrates were provided by the Shreddies
and the glucose drink vs. about 29 g with Cheerios.
According to published GI (404), the GI of Cheerios and
Shreddies are similar (about 84 and 75, respectively). The
cereal products were ingested with milk, which is insulino-
tropic and would probably result in lower GIs than calcu-
lated from the individual carbohydrate components, as well
as shortened blood glucose response profiles. Repeated bat-
teries of computerized tests of attention, working memory
and episodic memory were administered during the post-
prandial period (up to 210 min). The cereal breakfasts
conferred benefits for cognitive functions compared with
glucose or no breakfast, particularly towards the end of the
morning, with little difference in between the two cereal
breakfasts.
A study in younger children (6–11 years) consuming All
bran (GI = 42) and Coco Pops (GI = 77) allowed a stronger
comparison of the impact of varying breakfast GI (405)
using the same tests as employed by Wesnes et al. (401)
performed up to 130 min post-ingestion. The decline in
performance of attention tasks in the postprandial period
was more pronounced after the high-GI breakfast
meal. The reduction in decline in children’s performance
throughout the morning was attributed to the LGI cereal
breakfast. However, the ‘cognitively superior’ LGI break-
fast, in addition to being ‘lente’, also provided less available
carbohydrates, 16 vs. 30 g. In support of above, Mahoney
et al. (406) evaluated cognitive outcomes after LGI
(oatmeal) vs. HGI (ready-to-eat cereal [RTEC]), or no
breakfast in two groups of children (6–8 years and 9–11
years, respectively). Breakfast cereals were served with
skimmed milk and matched on total carbohydrates. Break-
fast intake per se improved performance on tasks requiring
the processing of complex visual display in the 9- to
11-year-olds compared with no breakfast. Better spatial
memory and auditory attention following the LGI oatmeal
breakfast compared with the HGI RTEC was shown in the
younger children. All effects observed were in the late post-
prandial phase. Benton et al. (407) provided three compos-
ite breakfast meals varying in both GI and GL to school
children (5–7 years). The consumption of a low-GL meal
was associated with better scores on memory, ability to
sustain attention and improved time spent on specific tasks
in the classroom. Differences in GL were achieved by
varying the GI of the breakfast products (GI 50–70) and the
carbohydrate content of the breakfasts, with dairy products
included in the high- and intermediate-GL breakfasts
only, potentially lowering the range of GI. Benefits were
observed on classroom behaviour, memory, reaction to
frustration and sustained attention in the later postprandial
phase (2–3 h after breakfast) with low GL (401,405). In a
recent study in healthy adolescents (11–14 years) (408),
cognitive performance was assessed and related to the GI
and GL characteristics of breakfast estimated from self-
reported data. Adolescents were divided into four groups
depending on the character of the breakfast; low GL + LGI
(n = 19), low GL + high GI (n = 11), high GL + LGI
(n = 11) and high GL + high GI (n = 19), and cognitive
functions were assessed between 90 and 120 min postpran-
dially. Different aspects of cognitive performance were
associated with each breakfast, e.g. high GL + LGI pro-
duced better information processing and working memory
performance in tasks that the subjects found ‘most diffi-
cult’, while high GI and high GL breakfasts were associated
with better immediate word recall and matrices perfor-
mance, respectively.
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Studies have also been performed in young healthy
adults. Benton and co-workers (409) investigated the
impact of two cereal breakfasts in young females. The
breakfast meals contained similar carbohydrate contents
and GI characteristics were predicted from in vitro enzyme
availability data (42 and 66, respectively). Glycaemic
response was measured for 230 min after breakfast while
episodic memory was recorded up to 220 min. The LGI
breakfast significantly improved memory function, particu-
larly in the late postprandial phase (150 and 210 min
after breakfast), with no concomitant differences in blood
glucose. Hence, cognitive outcomes could not be attributed
to late glycaemia per se. Other studies have, however, failed
to show significant differences in cognitive functions
related to the GI of breakfast meals in this age group. In a
study in adolescents (14–17 years) (410), an LGI (All bran
GI = 30) or a high-GI breakfast (Cornflakes GI = 77) was
provided after an overnight fasting. Glycaemic measure-
ments were performed up to 90 min, but no significant
differences in glycaemia were observed. Analysis of
remembering/forgetting indices revealed that the high-GI
breakfast induced cognitive benefits in comparison with the
LGI breakfast. However, immediate free recall, and short
and long delayed recall, respectively, tended to benefit from
the LGI breakfast, although this effect may be due to the
the way in which these scores were derived from subtests.
The rate of glucose delivery to the blood can be manipu-
lated by altering the chemical or physical structure of the
carbohydrate moiety, thus making it possible to examine
the impact of inducing very different glycaemic responses
on cognitive function (411). ISO, an isomer of SUC con-
taining an a-1,6 glycosidic linkage, is considered slowly but
completely digested and absorbed in the gastrointestinal
channel, providing a low but sustained glycaemic response
(412). ISO or SUC was consumed in milk-based drinks
in the morning, and glycaemic profiles were measured
continuously with cognitive performance assessed in the
postprandial phase up to 165 min. Immediate and delayed
verbal memory, psychomotor performance and serial
sevens were assessed. Despite large and significant differ-
ences in the amplitude of postprandial glycaemia, no major
differences occurred across the measures of cognitive func-
tion. Postprandial glucose and hormonal responses to
drinks with ISO and SUC in healthy subjects have been
reported in other studies using capillary blood (412). Inter-
estingly, these studies have indicated not only a reduced
initial glycaemic response following iso-maltulose but also
a prolonged net increment in blood glucose in the late
postprandial phase but failed to examine cognitive func-
tion. In contrast, in the only carefully controlled cognitive
study of ISO to date, Dye et al. (411) demonstrated that
capillary and interstitial blood glucose after both iso-
maltulose and SUC had returned to, or below fasting level,
respectively, after approximately 95 min, which is not con-
sistent with a slow and more distal digestion and absorp-
tion. This could reflect the good regulatory capacity of the
subjects or the effects of the milk-based vehicle where dairy
proteins will dampen glycaemia but nevertheless demon-
strates that even when the rate of glucose uptake differs
significantly, cognitive effects are not necessarily observed.
Using a factorial design, cognitive functions were inves-
tigated in young female adults (n = 168) after eight break-
fasts differing in GI (range 47–71), as well as in the amount
of carbohydrates and dietary fibre (413). In subjects with
poorer glucose tolerance, consuming more carbohydrates
resulted in more forgetting. In contrast, higher amounts of
carbohydrates improved reaction time after 90 min in the
poor regulators. The lowest levels of fibre (1.5 g) were
associated with poorer memory in subjects with poorer
glucose tolerance. However, blood glucose responses were
not affected by dietary fibre content, indicating that the
expected variation in GI was not achieved in the composite
meals but the timing of blood glucose sampling was such
that differences may have been missed.
No differences in cognitive performance were found after
test meals differing in GI in elderly subjects (60–82 years)
(414). Three test meals provided 50 g of available carbo-
hydrates from pearl barley (GI = 28), potatoes (GI = 56–
118) (415), glucose (GI = 100), and a placebo drink with
no carbohydrates and were consumed in a within-subjects
design. Cognitive tests were administered 15 min after
commencing the breakfast and 105 min postprandially.
Performance after the consumption of potatoes or barley
did not differ significantly from performance after the
placebo on any cognitive tests. However, the potential
impact of GI may have been obscured by the fact that not
all subjects managed to consume the breakfast meal prior
to cognitive testing. Nilsson et al. (399) tested working
memory and selective attention in healthy normal-weighted
middle-aged subjects after 50 g of glucose in drinks admin-
istered either as a bolus load, or by sipping to achieve a
rapid high peak followed by a steep decrease to below the
fasting value, or a smooth course of glycaemia, respectively.
Better performance in working memory (90 min) and selec-
tive attention (170 min) in the later postprandial period
was observed after sipping. In addition, subjects with
relatively better glucose tolerance performed better on
the cognitive tests than those with lower glucose tolerance
(albeit in the normal range). The cognitive functions
tested were enhanced by preventing a sharp decline in
blood glucose concentration and by maintaining a higher
glycaemia in the late postprandial period, respectively.
The same authors (416) recently confirmed the cognitive
benefits of a low but sustained net increment in blood
glucose in the late postprandial phase using an LGI food
prototype product compared with a high-GI breakfast
matched on carbohydrate content and gross nutrient
composition.
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Similar effects on cognitive performance after breakfast
have also been reported in type 2 diabetic subjects. Papani-
kolau and co-workers provided breakfasts consisting of
pasta, toasted white bread or water (417). Higher post-
prandial blood glucose AUC was associated with poorer
verbal memory, and in general the LGI pasta meal resulted
in better performance. However, both bread and pasta
resulted in higher scores for sustained attention than water.
Interestingly, the superior performance with pasta was not
seen in the earliest tests (15 min, immediate recall) but was
apparent between 62 and 100 min in the postprandial
phase.
General discussion
Of the 15 studies shown in Table 6, 4 do not permit con-
clusions to be drawn regarding the possible relationship
between postprandial glycaemia and cognitive performance
(408,409,413,418). Of the remaining 11, 2 found no
effects of GI characteristics (411,414), but while the design
of the test breakfasts in these studies was appropriate to
evaluate the potential influence of the GI, compliance to
the breakfast meals in the Kaplan study was poor. One
study reported benefits of HGI vs. LGI breakfasts (410)
with the effect in question based on a calculated cognitive
parameter.
In total nine studies showed cognitive benefits following
LGI breakfasts. The quality of the evidence in these studies
varies, and in many cases the GI of the test breakfasts are
estimates from international tables, with no actual glycae-
mic profiles provided. Furthermore, in many experiments
the test foods differ in a number of ways, not just in GI.
The course of glycaemia following breakfast in relation to
cognitive functions has been reported in six studies
(399,409,411,416,417,419). With one exception (411), the
findings favour LGI.
Of the four studies performed in children, three
employed experimental designs that allow conclusions
regarding the GI per se, or the GI character of the breakfast
tested at realistic portion sizes (401,405,406). All three
studies suggest benefits of LGI breakfast meals on the cog-
nitive domains of memory and attention.
The impact of the course of glycaemia on cognition
based on studies in young adults is inconsistent. The nature
of the cognitive task may affect its susceptibility to
enhancement by glucose (356,357,420), and in young
insulin-sensitive subjects, effects on cognitive functions
may be undetectable even if demanding cognitive tasks are
employed.
Most studies report effects on cognitive outcomes in the
later postprandial phase. Although benefits in cognitive
function in the late postprandial phase coincided with
higher late glycaemia in two of the studies (Nilsson et al.
unpublished) (399), such benefits are also reported with
LGI breakfasts in the absence of differences in blood glucose
levels (409), suggesting that the provision of glucose from
the circulation per se is not the only important factor for
brain function. Instead, the improvement in cognitive func-
tions seen in the late postprandial phase in some studies
with LGI breakfasts may also be secondary to improved
insulin sensitivity. Progressively, deterioration of glucose
regulation predicted poorer performance on working
memory and executive function in a group of healthy
middle-aged to elderly subjects (397), suggesting that
dietary interventions that improve glycaemic control are
important to protect cognitive functions. In light of the role
of insulin receptor activity in brain signalling (392,421–
423), effects on postprandial insulin sensitivity may be a
mechanism whereby LGI meals may confer benefits for
cognitive performance (424). Improvements in glucose
tolerance following an LGI meal can carry over from one
meal to another, ingested 4 h later (113,270,425,426).
Improved glycaemic regulation and lowered insulin demand
at the lunch meal following LGI breakfasts has been attrib-
uted to the slow and sustained carbohydrate absorption
resulting in lowered plasma FFA at lunch time (427). This
hypothesis is substantiated by the fact that sipping glucose
over 3.5 h, compared with a bolus load, resulted in a pro-
longed suppression of plasma glucagon, growth hormone
and FFA in the late postprandial period (428). As FFA level
is considered a marker of IR, this suggests that slow release
carbohydrates may beneficially modulate insulin sensitivity
in the postprandial phase, thus increasing glucose tolerance
at a subsequent meal ingested 4 h later (464).
Taken together, there is plenty of evidence to support IR
as a postprandial phenomenon, and that differences in GI
and/or the course of postprandial glycaemia may be of
importance in this context. The possible acute effects of a
meal on insulin sensitivity and insulin receptor signalling is
of potential relevance in relation to cognitive function
because, as described above, suppression of insulin receptor
signalling can compromise neuronal plasticity.
Conclusions
The conclusions from studies available to date are tem-
pered by a range of methodological limitations, e.g. poor
descriptions of meals or products ingested as well as of
cognitive tests administered, insufficient standardization of
the available carbohydrate content and nutrient composi-
tion of the meals, lack of adequate information on, or
physiological confirmation of, the course of postprandial
glycaemia, insufficient duration of the meal test and subse-
quent test period, or too few test subjects. Taken together,
the studies generally favour LGI meals for improved
memory and/or attention, particularly in children and
elderly, and mainly in the late postprandial phase. The
beneficial effects may be secondary to a smoother overall
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blood glucose profile with sustained availability of glucose
to the brain and/or to an acute improvement in insulin
sensitivity. More studies are needed to deduce the impact of
the course of glycaemia and related metabolic parameters
such as inflammatory markers, and acute measures of
insulin sensitivity on cognitive performance. Imaging tech-
niques may provide valuable information in this context.
Studies are needed to elucidate the relationship between
peripheral IR, as may occur in the postprandial phase, and
insulin receptor activity in the brain. Also needed are
studies of the impact of habitual consumption of low- vs.
high-GI diets on IRS and cognitive performance.
Overall conclusion
Tight glycaemic control is necessary to maintain health and
to prevent disease. This review provides an overview of
postprandial glucose in relation to body weight control,
oxidative stress, T2DM and CVD. It also addresses the
impact of exercise performance on blood glucose control
and utilization and the relationship between blood glucose
and cognitive function. Blood glucose responses are inter-
related with insulinaemic and lipidaemic responses, and the
mechanisms underlying blood glucose responses are related
to food intake, insulin secretion capacity and insulin sen-
sitivity. Thus, the blood glucose responses per se, as well as
the interrelated factors and underlying mechanisms, have
been discussed.
Body weight control
Studies suggest that the types of foods that elicit a lower
postprandial glucose response may be useful as part of an
overall strategy for combating obesity and its associated
burden of chronic disease, but the evidence for a direct role
of postprandial glucose per se in these effects is consider-
ably weaker. Overall, evidence from short-term studies of
GI is more convincing than that from longer-term studies in
terms of an effect on appetite regulation. However, it is not
clear that effects attributed to GI are actually driven by
variation in postprandial glucose responses per se, as
studies directly testing this are unsupportive. There is also
some evidence that LGI diets (via a slower uptake of car-
bohydrate) stimulate fat oxidation at the expense of carbo-
hydrate oxidation in the short-term (e.g. Brand-Miller et al.
(8)) and reduce body fat deposition (8,128). The mecha-
nisms relating glycaemic response to the regulation of body
weight have been examined in controlled feeding studies
(129) and involve acute hormonal and metabolic changes
that may decrease hunger and EI and affect nutrient parti-
tioning and fat oxidation (8). Of particular interest are also
gastrointestinal peptides that are released following food
consumption and which are involved in the control of
appetite and satiety (CCK, GLP-1, PYY and ghrelin).
There is currently little data on the chronic effects of
reducing postprandial glycaemia on body weight. The
recently completed Diogenes study has attempted to reduce
this knowledge gap, showing clear positive effects of an LGI
diet in reducing weight regain after weight loss. Again, it is
not clear whether the effect of an LGI diet is driven by a
reduced postprandial glycaemia per se, and multiple mecha-
nisms may be responsible for the positive effect on body
weight control. Recently published opinions on DRVs for
carbohydrates, dietary fibre, fats and water, adopted by
EFSA’s Panel on Dietetic Products, Nutrition and Allergies
(130), include the conclusion that evidence is still inconclu-
sive on the role of GI and GL in maintaining weight. It
is evident that there is a clear need for more long-term
well-designed human studies to evaluate how variation in
glycaemic response, induced by well-characterized low- or
high-glycaemic diets, affect EI, body composition and body
weight for biologically significant periods of time.
T2DM
Prospective cohort studies comparing diets with different
GI or GL have shown conflicting results with respect to
developing T2DM (i.e. EFSA opinions [130]). The Barclay
meta-analysis (187) included eight studies and reported
that an increased risk of diabetes was found when compar-
ing highest to lowest quintiles of both GI and GL. The
meta-analysis of Livesey included experimental studies and
showed that diets with an LGI have a beneficial impact on
fasting glucose, glycated protein and insulin sensitivity in
non-diabetic subjects. Unfortunately, insufficient data on
postprandial glucose profiles were available.
There is mechanistic evidence from animal and human
studies that elevated blood glucose and an altered pattern
of blood glucose response (i.e. late hypoglycaemia),
together with an elevated insulin concentration, leads to a
transitory deleterious metabolic and hormonal state, which
involves the liver, pancreas, skeletal muscle and lipid
metabolism interactions as well as incretins and inflamma-
tory parameters in healthy subjects. These phenomena are
exacerbated in impaired glucose-tolerant subjects. Thus,
there is proven evidence that reducing blood glucose and
insulin responses is beneficial to prevent T2DM genesis.
However, a problem in interpreting available literature
is that several studies utilizing theoretically LGI vs. high-GI
manipulations did not produce differences in blood glucose
response. A selection of intervention studies with reported
postprandial glycaemic profiles (n = 5) indicated that dif-
ferences in postprandial blood glucose response should be
more than 1.3 mmol L-1 and that insulin responses should
be significantly different to obtain clear metabolic effects.
One of the main issues in these studies is that the diet has
to be well controlled and well selected to be able to provide
a low glucose response via modifying the quality of carbo-
obesity reviews Postprandial glycaemia and health E. E. Blaak et al. 969
© 2012 ILSI Europe
obesity reviews © 2012 International Association for the Study of Obesity 13, 923–984, October 2012
hydrates. Thus, one of the challenges in clinical experi-
ments and moreover in ‘real life’ is to provide effective low
glucose-response diets in order to draw a more definite
conclusion on the role of postprandial glycaemia in the
prevention of diabetes.
Oxidative stress and CVD
Epidemiological evidence seems to indicate that there is an
independent relationship between post-challenge blood
glucose levels and CVD, even in non-diabetic people, and
this relationship seems to be continuous without any real
threshold. These data may be extrapolated with some
caution to postprandial blood glucose levels for which, at
the moment, we do not have direct evidence. The direct
association between high-GI/GL diets, which are able to
increase postprandial blood glucose, and CVD seems to
support the role of the postprandial blood glucose level as
an independent cardiovascular risk factor. In any case, it
is important to consider that LGI diets, particularly
if rich in dietary fibre, may reduce cardiovascular risk
through their action on other risk factors, especially LDL
cholesterol.
Whether postprandial glucose is a stronger risk marker
for CVD as compared with fasting glucose or HbA1c
remains controversial. Many studies have reported a stron-
ger association of CVD risk and postprandial or post-load
glucose than for CVD risk and HbA1c or mean blood
glucose. However, HbA1c and mean blood glucose show
stronger associations with CVD risk factors than do post-
prandial glycaemia or glucose variability in people with
diabetes (the ADAG study). Also, specifically targeting
postprandial glucose by using prandial insulin or megli-
tinides has not unequivocally resulted in improvement of
the CVD risk profile. Thus, it is difficult to differentiate
between the different indicators of glycaemic control,
HbA1c, fasting glucose, postprandial glucose and glucose
variability, because they are interlinked, which indicates
that the goal should be to achieve glycaemic status as near
to normal in all three measures of glycaemic control –
fasting glucose, HbA1c and postprandial glucose.
Among other factors, excessive protein glycation and
generation of oxidative stress and the induction of inflam-
mation may be underlying mechanisms linking chronic
hyperglycaemia and CVD. It has been hypothesized that
glycaemic variability may be even more important in the
induction of oxidative stress. However, the relationship
between glucose variability found in cell cultures and
animal studies could not be consistently reproduced in
human studies. Differences in methodology used for oxida-
tive stress quantification, as well as differences in duration
and frequency of periods with alternating glycaemia, may
be possible explanations. The metabolic syndrome may
support peripheral inflammation, for instance, by sensitiz-
ing leukocytes to up-regulate pro-inflammatory markers in
response to glucose, which in turn increases the risk for
T2DM and CVDs. These data indicate that effects may
vary with type of participant and related metabolic condi-
tion. Hence, we need conclusive evidence on the relation-
ship between postprandial glycaemia and CVD from
specific intervention studies with cardiovascular outcomes.
Exercise, postprandial glucose regulation and
physical working capacity
Depending on exercise intensity and duration, physical
work may have profound effects on the utilization of
glucose as a fuel in muscle. During intensive muscle con-
tractions an enhanced glucose uptake from the blood will
occur and thus the rate of ‘glucose disappearance’ from the
circulation after a meal preceding exercise or taken during
exercise will be enhanced. Maintaining high glucose avail-
ability can delay fatigue and thereby improve physical as
well as mental performance. Several lines of evidence show
that intense and lasting muscle work cannot be performed
without appropriate availability of carbohydrate and that
athletes perform longer at high exercise intensity when
glucose availability remains high.
The postprandial effects during exercise, as well as the
relative contribution of the individual substrates in the fuel
mix used during physical activity, depend on various
factors, including the amount of carbohydrate ingested,
the timing of intake, and the intensity and duration
of exercise. Studies with trained und untrained sedentary
individuals found similar metabolic responses following
high-glycaemic or low-glycaemic foods and similar differ-
ences in substrate metabolism at rest and during low- to
moderate-intensity exercise.
The effects of muscle contraction on glucose uptake
from the blood are distinct from the effects of insulin and
are known to continue even for many hours post-exercise.
These effects of exercise lead to both a reduced post-
exercise need for insulin production and an enhancement of
insulin sensitivity. Because of these observations, regular
exercise is recommended as an important measure to
manage postprandial blood glucose within ‘more healthy
levels’ in patients suffering from T2DM.
Cognitive function
Studies that report the course of glycaemia following
breakfast have, in the main, shown a more favourable
outcome for LGI, with one exception. Although young
children might be expected to be more susceptible to effects
of brief fasting, such as that occurring overnight, because of
the greater brain metabolic demands relative to their liver
and muscle glycogen stores, and lower capacity for gluco-
neogenesis, studies are required to confirm the effects of
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brief (overnight) fasts on cognitive function and the impact
of carbohydrate ingestion.
Individuals with impared glucose tolerance or T2DM are
also likely to be particularly vulnerable to impairments or
less optimal cognitive function because of their elevated
metabolic risk factors such as IR, oxidative stress and an
impaired glycaemic response, which may all impact nega-
tively on cognitive function. Data on the relationship
between postprandial glycaemia and cognitive performance
are inconclusive because of methodological limitations of
the available studies which suffer from poor description of
the meals or products consumed and the cognitive tests
performed. There is insufficient information on the stan-
dardization of available carbohydrate or the nutrient com-
position of meals, postprandial glycaemia and the duration
of the post-ingestion test period, and studies that explore
postprandial glucose in individuals with varying degrees of
CVD risk in terms of cognitive impact are required.
In conclusion, there is mechanistic evidence linking post-
prandial glycaemia and glycaemic variability to maintain-
ance of optimal glycaemic control, the prevention of
obesity, diabetes and CVD, to optimizing exercise and cog-
nitive performance. However, data on the importance of
postprandial glycaemia per se remain, in general, inconclu-
sive because of storng interrelationships with other risk
factors, lack of direct measures of glycaemic control and
methodological limitations. It is evident that more random-
ized controlled dietary intervention trials are necessary
inducing effective low glucose-response diets to be able to
draw more definite conclusions on the role of postprandial
glycaemia in relation to health. Such studies should pay
close attention to the standardization of diets and include
the measurement of postprandial glycaemic profiles over
longer periods of time. The relationship between postpran-
dial glucose, diabetes and CVD is a continuum, indicating
that early intervention to normalize postprandial glucose
(and related indicators of hyperglycaemia and hyperlipi-
daemia) may be required.
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